Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
1616796	cb-vekaas	— (—)	9234	32971	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma

1502

2419

3.32

319.43

3.8

2.6

—

Cardiovascular diseases (excluding rheumatic etc)

1220

1918

3.74

317.33

4.5

2.1

—

Diabetes, insulin treatment (Kela reimbursement)

2261

5515

2.53

313.19

4.4

3.2

—

Endocrine, nutritional and metabolic diseases

1589

2577

3.18

312.93

4.0

2.7

—

Diabetes, varying definitions

2217

5176

2.56

312.85

4.1

3.1

—

Asthma (only as main-diagnosis), excluding more controls

1270

2063

3.59

312.44

3.7

2.5

—

Early onset COPD, excluding more controls

574

1008

5.97

312.42

5.4

2.9

—

Insulin, fast-acting or short human

1184

3330

3.72

307.65

5.3

3.3

—

Covid-19 confirmed case

1260

3335

3.98

307.65

5.0

3.4

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2707

5904

3.26

307.65

4.7

3.1

—

Sleep apnoea

2240

5430

2.74

307.65

3.7

3.5

—

Asthma, excluding more controls

1441

2063

3.72

307.65

3.8

2.5

—

Malaise and fatigue

1538

3007

4.28

307.65

3.5

3.4

—

COPD/asthma related infections

2207

3765

3.00

307.65

4.1

2.7

—

Insulin, intermediate and long-acting

1608

5037

3.22

307.65

4.9

3.4

—

First line medication for Crohn's disease

2546

5186

2.71

307.65

4.6

2.8

—

Insulin, fast-acting

1177

3143

3.93

307.65

5.3

3.3

—

2613

3762

4.36

307.65

4.9

2.7

—

COPD (mode)

989

1346

6.08

307.65

5.2

2.8

—

Insulin medication

1773

4433

3.49

307.65

5.0

3.3

—

ILD medications

2535

5563

2.52

307.65

4.8

2.8

—

Hypertensive diseases

1693

2915

3.36

307.65

4.6

2.6

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2613

3762

4.36

307.65

4.9

2.7

—

Renal tubulo-interstitial diseases

3125

4964

4.92

307.65

5.5

2.6

—

Other diseases of the respiratory system

850

1811

5.05

307.65

7.8

3.2

—

Implicit bacterial Sepsis

1500

2868

4.91

307.65

6.2

2.7

—

Kidney transplant status

383

331

14.00

307.65

11.2

3.5

—

Glomerular disorders in diseases classified elsewhere

626

895

7.87

307.65

8.1

3.5

—

Heart failure, not strict

2420

3701

4.66

307.65

5.6

2.6

—

Pneumonias (Asthma/COPD co-morbidities)

2933

5264

3.87

307.65

4.8

2.7

—

Fever of other and unknown origin

1744

3600

4.49

307.65

4.8

3.4

—

All kidney diseases

3147

5084

4.40

307.65

5.2

2.5

—

Implicit viral Sepsis

964

2093

4.86

307.65

6.1

2.6

—

Influenza and pneumonia

2930

5212

3.69

307.65

4.8

2.7

—

COPD/asthma/ILD related infections

2207

3765

3.00

307.65

4.1

2.7

—

Sleep apnoea, including avohilmo

2280

5535

2.61

307.65

3.7

3.5

—

Hypertension

1693

2914

3.36

307.65

4.6

2.6

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2221

5572

2.65

307.65

5.0

3.1

—

Other heart diseases

1024

1451

4.74

307.65

5.2

2.1

—

Other bacterial diseases

2696

5358

3.29

307.65

4.7

2.9

—

Asthma, unspecified (mode)

1215

2251

4.18

307.65

4.0

2.6

—

Nephropathy related operations

792

960

9.59

307.65

10.4

3.4

—

L04AD Calcineurin inhibitors

530

727

8.12

307.65

9.9

3.7

—

Implicit viral Sepsis

772

1395

5.92

307.65

6.5

2.7

—

Heart failure, strict

1909

3492

4.05

307.65

5.5

3.1

—

Persons encountering health services in other circumstances

1528

3026

5.32

307.65

3.9

3.0

—

Bacterial infection, other or unspecified

1659

4022

3.62

307.65

5.0

3.1

—

Other disorders of fluid, electrolyte and acid-base balance

1234

2322

5.41

307.65

5.0

3.4

—

Bacterial Sepsis

1668

3162

4.76

307.65

6.1

2.7

—

Other medical care

1466

3392

4.07

307.65

4.6

2.9

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2140

4871

2.71

307.65

4.3

3.2

—

Anaemias

706

324

14.92

307.65

5.3

2.1

—

Other diseases of pleura

1639

3652

4.16

307.65

5.9

3.2

—

Presence of other functional implants

1709

3561

3.46

307.65

4.1

3.5

—

Implicit Sepsis

2548

4621

4.20

307.65

5.4

2.6

—

Glomerular diseases

874

1457

6.60

307.65

8.0

3.5

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2833

5372

3.72

307.65

4.8

2.8

—

Persons encountering health services for specific procedures and health care

2619

5564

2.89

307.65

5.1

2.7

—

Hypertensive diseases (excluding secondary)

1177

1392

5.06

307.65

4.9

2.1

—

Persons encountering health services in other circumstances, wide

2619

5510

2.50

307.65

4.5

3.1

—

Metabolic disorders

2290

4951

2.89

307.65

4.3

3.2

—

Care involving dialysis

604

519

14.04

307.65

11.1

3.2

—

Transplanted organ and tissue status

520

604

9.71

307.65

10.0

3.5

—

Asthma, unspecified (mode), excluding more controls

1172

1912

4.72

307.65

4.0

2.5

—

Explicit Sepsis

1601

3196

4.94

307.65

5.9

2.7

—

Acute renal failure

1046

1572

7.32

307.65

6.4

2.8

—

General symptoms and signs

2399

4180

2.94

307.65

3.8

3.3

—

Dyspnoea

2385

5990

3.03

307.65

4.2

3.4

—

Type 2 diabetes, wide definition

2011

4221

3.14

307.65

4.6

3.2

—

All-cause Heart Failure

1874

3442

4.04

307.65

5.4

3.1

—

Viral Sepsis

772

1397

5.92

307.65

6.5

2.7

—

Respiratory insufficiency

504

372

15.47

307.65

9.4

2.8

—

Chronic kidney disease

1875

2422

8.54

307.65

7.0

2.9

—

Heart failure,strict

1768

2687

4.90

307.65

5.6

2.7

—

Bacterial infection, other or unspecified

1543

3836

3.63

307.65

5.0

3.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1775

5399

3.11

307.65

5.0

3.4

—

ILD medications: prednisolone, methylprednisolone, prednisone

2568

5492

2.67

307.65

5.0

2.8

—

Other bacterial diseases

2723

5356

3.54

307.65

4.9

3.0

—

Hypertension, essential

1688

2840

3.45

307.65

4.3

2.6

—

All pneumoniae

2943

5288

3.85

307.65

4.8

2.8

—

Heart failure and coronary heart disease

1353

2727

3.69

307.65

5.6

3.4

—

Pneumonia, organism unspecified

2819

4878

4.21

307.65

4.9

2.8

—

Abnormalities of breathing

2225

4163

3.19

307.65

3.9

3.3

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2527

4647

3.98

307.65

5.3

2.5

—

Other respiratory disorders and diseases

850

1811

5.05

307.65

7.8

3.2

—

All chronic kidney diseases

2493

3229

6.79

307.65

6.1

2.6

—

Diabetes mellitus

2244

5160

2.60

307.65

4.1

3.1

—

Secondary hypertension

481

279

19.44

307.65

8.9

1.9

—

Other septicaemia

1427

3001

4.85

307.65

5.9

3.2

—

Heart failure and bmi 25plus

1168

2125

3.92

307.65

5.6

3.1

—

Dialysis, with operation codes

793

806

11.36

307.65

10.2

3.0

—

Septicaemia

1557

3297

4.67

307.65

5.9

3.2

—

Implicit Sepsis

2471

4420

4.41

307.65

5.5

2.6

—

Renal failure

2463

3351

7.15

307.65

6.4

2.8

—

Aplastic and other anaemias

1368

4121

3.22

307.65

5.3

3.5

—

Heart failure and antihypertensive medication

909

768

8.24

307.65

6.2

2.5

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2533

4676

3.86

307.65

5.2

2.5

—

Implicit bacterial Sepsis

1585

3061

4.72

307.65

6.1

2.7

—

Oral corticosteroids

2492

5894

2.56

307.65

4.4

3.1

—

Extracorporeal dialysis

458

457

12.21

307.65

11.1

3.9

—

Dialysis

304

226

16.52

307.65

11.8

2.9

—

Acute tubulo-interstitial nephritis

1571

3996

3.50

307.65

5.1

2.6

—

COPD

1303

3391

3.27

306.36

5.1

3.4

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

417

302

10.47

305.10

5.4

3.0

—

ILD, hospital admission 2, with pulmonary infections

416

539

8.45

305.09

5.6

3.0

—

Provisional assignment of new diseases of uncertain etiology

1416

4888

2.99

302.30

4.9

3.3

—

Codes for special purposes

1417

4898

2.98

301.77

4.9

3.3

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

586

647

6.52

300.15

5.6

2.2

—

ILD medications: immunosuppressive drugs

1459

4738

2.94

299.06

6.0

2.8

—

Any reimbursement code in KELA

1009

1198

4.30

296.07

4.0

1.8

—

Inflammatory bowel disease treatment related agents

2502

6046

2.36

293.16

4.5

3.1

—

GASTRO-related operations

1559

2587

3.08

290.52

4.2

2.4

—

Any gastric operation

1559

2587

3.08

290.52

4.2

2.4

—

Type 2 diabetes

2088

4895

2.54

289.85

4.2

3.1

—

Other chronic obstructive pulmonary disease

1241

3288

3.24

287.75

5.2

3.4

—

Any death

1543

3971

2.88

282.86

5.0

3.3

—

Other pulmonary diagnosis

1490

2443

3.11

282.45

4.0

2.6

—

Viral pneumonia

474

771

6.59

280.92

5.8

3.0

—

Hypo-osmolality and hyponatraemia

607

1251

5.13

275.84

4.4

3.5

—

ILD, hospital admissions 3, with pneumonia sepsis

387

521

8.21

275.33

5.8

3.1

—

Other anaemias

1229

3922

3.10

274.34

5.0

3.4

—

Diabetes medication

2199

5518

2.41

274.23

4.2

3.2

—

Other and unspecified anaemias

1222

3904

3.10

273.66

5.0

3.4

—

Other heart diseases, wide

1831

4366

2.61

272.56

4.6

2.9

—

Asthma (only as main-diagnosis)

1309

2419

3.19

272.01

3.7

2.6

—

Erysipelas

1582

4553

2.72

268.10

4.6

3.0

—

Bronchitis

2334

6508

2.30

267.45

4.4

3.2

—

Excluding asthma or asthma-COPD overlap

1459

2443

3.05

267.40

3.9

2.6

—

Oxycodone

1022

2803

3.42

266.44

4.4

3.5

—

ILD differential diagnosis

1455

2439

3.04

266.17

3.9

2.6

—

COPD differential diagnosis

1455

2440

3.04

266.01

3.9

2.6

—

Non-ischemic cardiomyopathy

848

1795

3.97

264.57

5.3

2.9

—

Invasive ventilation

377

520

8.17

263.72

7.5

3.5

—

Later onset COPD, excluding more controls

610

944

5.25

262.54

5.0

2.8

—

COPD, hospital admissions

1262

3680

3.01

261.04

5.2

3.4

—

COPD, hospital admission 2, with asthma infections

1004

2613

3.45

258.93

5.6

3.4

—

Disorders resulting from impaired renal tubular function

270

253

13.08

258.14

9.8

3.9

—

Other chronic obstructive pulmonary disease, including avohilmo

1399

4241

2.82

256.46

4.9

3.5

—

COPD, early/later onset

1260

3698

2.98

255.97

5.1

3.5

—

L04AA Selective immunosuppressants

690

1704

4.26

251.18

8.1

3.2

—

Unspecified kidney failure

422

688

6.68

250.60

6.5

3.0

—

Substance abuse, excluding more controls

1320

4077

2.83

248.42

3.8

3.6

—

Asthma (mode)

1346

2439

3.01

247.68

3.5

2.6

—

COPD related to multimorbidity

1136

3224

3.10

246.30

5.3

3.4

—

Diabetic nephropathy, excluding more controls

623

1142

4.88

245.89

7.0

3.1

—

Other acute lower respiratory infections

1346

4788

2.76

245.88

5.0

3.4

—

Disorders of other endocrine glands

1106

3681

3.05

244.67

5.2

3.3

—

Atrial fibrillation and flutter

630

838

5.02

244.22

4.6

2.2

—

Acute bronchitis

1102

3657

3.05

243.64

5.1

3.4

—

Hypothyroidism (congenital or acquired)

454

341

7.69

241.54

3.4

2.0

—

Cardiovascular diseases

1085

1751

3.39

240.95

4.3

2.1

—

Depression medications

503

358

7.21

238.94

3.1

1.9

—

Type 1 diabetes, wide definition, subgroup 1

593

1354

4.57

238.11

5.4

3.3

—

Nausea and vomiting

749

1985

3.84

237.45

4.7

3.6

—

Intracranial trauma

1174

2799

3.01

235.54

3.6

3.4

—

Hypothyroidism, levothyroxine purchases

446

339

7.60

235.50

3.3

2.1

—

Hypothyroidism and >3 levothyroxin purchases

446

339

7.60

235.50

3.3

2.1

—

Infections, IBD-co-morbidities

407

411

7.35

234.86

6.6

2.9

—

Tramadol

1626

3964

2.57

234.39

4.2

3.3

—

Erysipelas

1269

4144

2.78

232.72

4.9

3.1

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

868

2201

3.54

231.93

5.9

3.4

—

Type 1 diabetes

685

1777

4.00

231.41

5.4

3.3

—

Pulmonary heart disease, diseases of pulmonary circulation

916

2892

3.30

230.19

4.7

3.5

—

Codeine

1865

4274

2.41

228.19

3.5

3.2

—

Cardiac arrhythmias

1045

2157

3.21

227.75

4.0

2.6

—

Bleeding

1842

5726

2.34

224.93

4.6

3.4

—

Hyperlipidaemia, other/unspecified

996

3046

3.12

224.41

4.2

3.4

—

Type 1 diabetes, wide definition

610

1492

4.26

223.72

5.4

3.3

—

Valvular heart disease excluding rheumatic fever

1026

2431

3.13

220.25

4.9

3.0

—

Volume depletion

392

675

6.29

220.04

5.9

3.6

—

Diarrhoea and gastroenteritis of presumed infectious origin

1587

6050

2.41

219.55

4.7

3.2

—

Other dialysis

230

219

12.95

217.78

12.4

3.9

—

Cerebrovascular diseases (FINNGEN)

593

933

4.62

217.37

4.4

2.2

—

Benzodiazepine use

2119

6837

2.17

216.59

4.0

3.4

—

2281

5523

2.17

216.00

4.3

3.2

—

Non-rheumatic valve diseases

1015

2417

3.11

215.78

4.9

3.0

—

Pleural effusion

536

1233

4.63

215.12

5.0

3.1

—

Other nutritional deficiencies

1412

5411

2.51

214.98

4.7

3.3

—

Exposure to unspecified factor

2090

7083

2.16

213.20

4.2

3.4

—

Atrial fibrillation and flutter with reimbursement

513

623

5.40

212.77

4.2

2.2

—

Concussion

1007

2776

3.02

212.14

3.4

3.5

—

Symptoms and signs involving the circulatory and respiratory systems

1910

4171

2.33

212.01

3.6

3.2

—

Antihypertensive medication - note that there are other indications

1074

1843

3.14

211.65

4.5

2.2

—

Certain infectious and parasitic diseases

1847

3979

2.36

211.02

4.3

2.7

—

Convulsions, not elsewhere classified

589

1448

4.16

209.98

4.1

3.4

—

Mental and behavioural disorders due to psychoactive substance use

1390

5293

2.49

206.93

3.7

—

Iron deficiency anaemia

1062

3805

2.84

206.09

4.8

3.3

—

Pain in throat and chest

1610

4050

2.43

205.84

3.4

3.3

—

Ischemic heart diseases

1657

4231

2.40

205.73

4.6

3.2

—

Sleep disorders (combined)

2244

5603

2.14

205.69

3.6

3.5

—

Gout

840

2329

3.31

205.48

5.7

3.6

—

Intestinal infectious diseases

1978

7070

2.16

204.08

4.6

3.3

—

Extreme obesity with alveolar hypoventilation

234

247

10.96

203.96

8.0

3.0

—

Opioids

1882

4340

2.29

202.75

3.7

3.2

—

Type 2 diabetes, definitions combined

1815

4741

2.29

201.78

3.8

3.1

—

Other CVD (FINNGEN)

316

325

7.93

200.61

4.3

2.1

—

Hypokalaemia

403

775

5.54

200.17

4.1

3.4

—

Diabetic maculopathy, excluding more controls

389

729

5.71

199.06

5.8

3.4

—

Type 2 diabetes, strict (exclude DM1)

1821

4797

2.27

198.57

3.8

3.1

—

Other disorders of kidney and ureter

476

1065

4.80

198.43

8.2

3.8

—

Other antidepressants

2100

5052

2.16

197.54

3.7

3.5

—

Obesity due to excess calories

1043

3847

2.79

197.15

4.7

3.3

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1267

4027

2.59

196.95

4.6

3.5

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

731

1263

3.73

196.86

4.2

2.1

—

Asthma, hospital admission 2, infections

1348

5500

2.46

196.81

4.3

3.5

—

Asthma-related infections

1348

5500

2.46

196.81

4.3

3.5

—

Nutritional anaemias

1192

4521

2.61

196.63

4.6

3.5

—

Chronic lower respiratory diseases

2380

6307

2.04

194.83

4.1

3.3

—

Obesity related asthma

851

2840

3.10

194.11

4.4

3.5

—

Pulmonary embolism

807

2621

3.20

193.37

4.4

3.5

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

609

1643

3.80

192.96

3.3

3.4

—

Complications of surgical and medical care, not elsewhere classified

2026

6717

2.10

190.42

4.5

3.3

—

Parasetamol

1400

2811

2.56

190.28

3.9

3.2

—

1391

5209

2.41

190.04

3.8

3.7

—

Obesity

1302

5234

2.45

189.37

4.8

3.3

—

Pulmonary heart disease

807

2659

3.16

188.67

4.4

3.6

—

Percutaneous Coronary Intervention

1554

4104

2.37

188.53

4.7

3.2

—

Obesity and other hyperalimentation

1306

5264

2.44

188.19

4.8

3.3

—

1342

5130

2.42

186.59

3.7

—

Episodal and paroxysmal disorders

2104

5143

2.11

186.48

3.5

—

Hard cardiovascular diseases

1616

4230

2.32

186.44

4.4

3.3

—

Other respiratory diseases principally affecting the interstitium

594

1635

3.85

186.34

5.5

3.6

—

Coronary revascularization (ANGIO or CABG)

1549

4105

2.36

185.92

4.7

3.2

—

Type 2 diabetes, definitions combined, including avohilmo

1783

4745

2.22

185.71

3.7

3.1

—

Gout, FINNGEN

840

2853

3.06

185.57

5.7

3.5

—

Substance abuse

1320

5241

2.42

185.40

3.8

3.7

—

Other (not insulin) diabetes medications

1866

5177

2.17

184.77

3.8

3.2

—

Hypertensive heart and/or renal disease

623

1253

3.84

182.99

5.5

3.0

—

Glomerulonephritis

382

763

5.41

182.66

7.9

4.0

—

Asthma-related pneumonia

936

3414

2.83

180.66

4.9

3.5

—

Asthma, hospital admissions 3, pneumonia

936

3419

2.82

180.13

4.9

3.5

—

Asthma-related pneumonia or sepsis

936

3419

2.82

180.13

4.9

3.5

—

Syncope and collapse

939

2893

2.84

179.16

3.4

—

Gout, unspecified

636

1895

3.54

176.67

5.9

3.6

—

Poisoning by drugs, medicaments and biological substances

601

1719

3.63

176.49

3.6

3.5

—

Adjustment and management of implanted device

540

1446

3.92

175.70

4.2

3.1

—

Mental and behavioural disorders due to alcohol

1185

4711

2.48

175.51

3.7

—

Hydronephrosis

352

674

5.54

175.49

5.2

2.9

—

Venous thromboembolism

1234

5026

2.43

175.37

4.3

3.5

—

Gout, strict definition

589

1681

3.71

175.20

5.9

3.6

—

Personality disorders, excluding more controls

543

1455

3.84

174.96

3.6

3.4

—

Poisoning by medicine

561

1543

3.78

174.84

3.6

3.5

—

370

745

5.21

173.65

4.5

2.8

—

Hernia of abdominal wall, postoperative

422

948

4.61

172.95

5.1

2.7

—

Gout, idiopatic and unspecified

734

2415

3.18

172.84

5.8

3.6

—

COPD-related respiratory insufficiency

423

965

4.70

172.05

8.3

3.6

—

Polyarthropathies

1461

4200

2.32

171.92

4.8

3.4

—

Other interstitial pulmonary diseases

514

1361

4.01

170.87

5.2

3.7

—

Interstitial lung disease

514

1375

3.97

168.40

5.2

3.7

—

Interstitial lung disease endpoints

514

1375

3.97

168.40

5.2

3.7

—

All influenza

588

1708

3.56

168.33

5.7

2.9

—

Viral pneumonia (unknown virus, not influenza)

288

479

6.56

167.96

6.5

3.7

—

Hyperkalaemia

259

389

7.35

167.15

7.3

3.6

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

454

1111

4.27

167.12

3.5

3.4

—

DVT of lower extremities and pulmonary embolism

1006

3950

2.61

166.70

4.3

3.6

—

Alcohol use disorder, Swedish definition

1245

4929

2.37

165.77

3.9

3.7

—

ILD, hospital admissions

505

1352

3.97

165.29

5.1

3.8

—

Major coronary heart disease event

1628

4565

2.19

164.94

4.7

3.3

—

Diabetic nephropathy

627

1923

3.47

164.18

7.0

3.6

—

Emergency coronary revascularization (for ACS)

1693

4871

2.15

164.17

4.7

3.4

—

Codeine or tramadol medication

2184

6154

1.97

163.93

3.6

3.5

—

Neurological diseases, wide definition

532

609

4.47

163.59

3.6

2.7

—

Oedema, not elsewhere classified

693

2236

3.14

162.74

4.6

3.3

—

Diseases of the respiratory system

1085

2051

2.69

161.46

4.0

2.6

—

Other and unspecified iron deficiency

819

2960

2.85

161.36

4.7

3.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1398

5744

2.23

159.87

4.6

3.5

—

COPD, hospital admissions 1, only main diagnosis

916

2975

2.73

159.36

5.5

3.5

—

Morphin

151

121

15.13

159.18

7.1

3.9

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1998

5471

2.01

159.00

4.9

3.0

—

Coronary atherosclerosis

1283

3481

2.38

158.98

4.7

3.3

—

Neurological diseases

1565

3574

2.23

158.15

3.6

3.5

—

968

3820

2.57

156.77

4.3

3.4

—

Symptoms and signs involving the urinary system

1581

5774

2.13

156.55

4.0

3.6

—

Autoimmune diseases excluding thyroid diseases

1985

5481

2.00

156.38

4.4

3.2

—

Disorders of mineral metabolism

288

514

6.01

155.52

5.1

3.7

—

Diseases of arteries, arterioles and capillaries

1437

4907

2.21

155.34

4.9

3.5

—

Anaemia in chronic diseases classified elsewhere

163

153

12.82

155.29

9.2

3.1

—

Other disorders of urethra and urinary system

1395

4587

2.24

154.95

4.4

3.4

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

565

718

4.01

153.28

3.6

3.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

617

1936

3.28

153.24

3.2

3.8

—

Acute upper respiratory infections of multiple and unspecified sites

1487

5188

2.16

153.05

4.4

3.3

—

Contact with and exposure to communicable diseases

652

2137

3.12

151.65

3.5

3.4

—

Persons with potential health hazards related to communicable diseases

783

2827

2.81

151.27

3.7

3.4

—

Autoimmune diseases excluding thyroid diseases, strict definition

1912

5310

2.00

149.88

4.3

3.2

—

Mood disorders, excluding more controls

1720

5054

2.06

149.53

3.8

3.4

—

Autoimmune diseases

2083

5510

1.95

149.01

4.1

3.2

—

Lung cancer and mesothelioma

427

901

4.20

148.12

3.8

2.8

—

Conduction disorders

640

1664

3.21

147.87

4.4

2.9

—

Symptoms and signs involving the digestive system and abdomen

1880

4729

2.02

147.87

3.8

3.5

—

Any mental disorder

2027

5241

1.96

147.40

3.7

3.5

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1020

4275

2.44

146.43

3.8

—

Headache

1089

3682

2.40

146.36

3.6

3.2

—

Sub-endpoint used in defining T1D endpoints

726

2547

2.89

146.26

5.4

3.6

—

Constipation

1752

6142

2.01

146.20

3.9

3.6

—

Other diseases of blood and blood-forming organs, wide

580

1836

3.29

145.48

4.5

3.6

—

Genitourinary diseases

1095

2200

2.54

145.43

4.7

2.6

—

Early onset COPD

574

1814

3.29

144.35

5.4

3.5

—

Biguanides

1773

5463

2.01

144.24

3.7

3.4

—

Disorders of lipoprotein metabolism and other lipidaemias

1497

4408

2.14

143.98

4.0

3.3

—

Abdominal and pelvic pain

1857

4729

2.00

142.31

3.7

3.5

—

Paroxysmal tachycardia

395

790

4.29

140.95

4.8

2.1

—

Liquid cancers, helper endpoint

830

2789

2.67

140.04

4.2

3.7

—

Implicit fungal Sepsis

230

367

6.75

139.35

7.5

2.6

—

Used for control exclusion in common control thyroid runs

1958

5155

1.94

139.08

4.0

3.2

—

Schizophrenia or delusion, excluding more controls

613

2026

3.07

138.94

3.8

3.5

—

Complications of procedures, not elsewhere classified

1560

6474

2.03

138.91

4.4

3.4

—

Disorders of gallbladder, biliary tract and pancreas

1882

6227

1.93

138.76

3.9

3.5

—

Alcohol use disorder, ICD-based

945

3944

2.46

138.67

3.7

—

Ischaemic heart disease, wide definition

1461

4332

2.13

138.46

4.4

3.4

—

STROKE

941

2570

2.53

136.32

4.0

2.9

—

Myocardial infarction

1006

2965

2.44

135.11

4.9

3.2

—

Haemorrhage from respiratory passages

736

2462

2.76

134.58

4.8

3.4

—

Other diseases of urinary system

1884

5565

1.93

134.43

4.1

3.4

—

Other general symptoms and signs

177

216

8.71

134.42

3.5

3.0

—

Anxiety disorders, excluding more controls

1444

4553

2.09

133.66

4.0

3.4

—

Pain in limb

1596

5409

2.00

132.11

4.0

3.5

—

Diarrhoea and gastroenteritis of presumed infectious origin

1896

6714

1.89

131.44

4.2

3.3

—

Adrenocortical insufficiency

165

196

9.41

130.72

5.2

3.6

—

ILD, hospital admissions 1, main diag only

428

1210

3.75

129.35

5.3

3.7

—

Suicide or other Intentional self-harm

558

1846

3.12

129.32

3.5

—

Other disorders of adrenal gland

188

264

7.83

128.99

5.3

3.4

—

Disorders of lens

1290

3779

2.17

128.85

5.0

3.4

—

Chronic nephritic syndrome

190

272

7.84

128.74

8.3

3.2

—

Diseases of the digestive system

1025

4560

2.29

128.10

4.7

3.6

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

609

2126

2.94

127.94

3.3

3.4

—

Endocrine disorders, other/unspecified

126

110

13.57

125.56

3.4

2.5

—

Retention of urine

828

2744

2.55

125.46

4.2

3.7

—

Other soft tissue disorders, not elsewhere classified

1784

5546

1.91

125.25

3.7

3.5

—

Complications of medical and surgical care

1422

6631

2.01

125.23

4.3

3.4

—

Disorders of calcium metabolism

225

393

6.17

124.56

5.2

3.7

—

Other functional intestinal disorders

959

3903

2.33

123.50

4.0

3.6

—

Other reaction to severe stress, and adjustment disorders

692

2634

2.68

122.90

4.4

3.2

—

Problems related to lifestyle

276

582

4.96

122.82

4.2

3.2

—

Intestinal infectious diseases

2101

6736

1.80

122.58

4.3

3.3

—

Fall on same level

2075

6317

1.82

122.30

3.9

3.5

—

Hypertensive Renal Disease

156

189

9.07

121.26

7.4

3.1

—

Asthma (diagnoses ohter than nonallergic)

1636

7270

1.89

119.96

3.8

3.5

—

Care involving use of rehabilitation procedures

1111

4833

2.15

118.11

3.8

2.8

—

Mood [affective] disorders

1841

6564

1.84

118.01

3.8

3.5

—

Mood disorders

1844

6569

1.84

117.87

3.8

3.5

—

Major coronary heart disease event excluding revascularizations

1154

3616

2.17

116.73

4.7

3.3

—

Diagnoses used for exclusion with ILD

626

2338

2.77

116.32

4.1

3.6

—

Explicit bacterial Sepsis

285

646

4.63

116.18

6.1

2.9

—

Infections of the skin and subcutaneous tissue

1139

5456

2.11

116.06

4.9

3.4

—

Hypertensive Heart Disease

481

1175

3.30

115.32

5.0

3.0

—

Fungal Sepsis

162

221

8.05

114.02

8.3

2.6

—

Implicit fungal Sepsis

154

199

8.54

113.65

8.4

2.6

—

Substance use, excluding alcohol

447

1406

3.28

112.99

4.1

3.6

—

Pacemaker

792

3205

2.44

112.84

4.5

3.7

—

Peripheral artery disease

972

3519

2.25

111.74

5.3

3.5

—

Hypothyroidism, drug reimbursement

199

204

7.03

111.39

4.1

2.1

—

Personality disorders

543

1921

2.90

111.39

3.6

3.4

—

Depression

1682

6236

1.85

110.85

3.7

3.5

—

Insulin, fast-acting (human)

353

968

3.79

110.76

5.5

3.2

—

Lung diseases due to external agents

414

1265

3.43

110.53

4.6

3.8

—

Abnormalities of heart beat

652

2485

2.62

110.48

3.4

3.3

—

Bacterial pneumoniae

744

2687

2.49

110.44

5.4

2.8

—

Certain infectious and parasitic diseases

1235

2966

2.11

109.62

4.2

2.8

—

Diseases of liver

740

3079

2.47

109.55

4.2

3.7

—

Use of hypnotics and sedatives

1916

6221

1.79

109.26

3.8

3.5

—

Disorders of adult personality and behaviour

562

2051

2.81

108.68

3.4

—

Abnormal spermatozoa

383

1131

3.59

108.58

4.0

—

AV-block

409

1074

3.45

108.08

4.7

3.0

—

Injuries to the head

1993

7064

1.75

108.00

3.8

3.5

—

Intracranial injury

1151

5442

2.03

106.31

3.6

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

573

2140

2.75

106.16

3.8

3.6

—

Glucagon-like peptide-1 (GLP-1) analogues

573

2140

2.75

106.16

3.8

3.6

—

Other arrhythmias

1008

3554

2.17

106.13

3.4

2.9

—

Other diseases of the digestive system

750

3192

2.42

105.69

4.8

3.6

—

Psychiatric diseases

1703

4661

1.85

104.76

3.8

3.5

—

Pain, not elsewhere classified

492

1705

2.95

104.60

3.8

3.3

—

Anxiety disorders

1539

5828

1.86

104.26

3.9

3.4

—

Later onset COPD

699

2270

2.53

103.59

4.9

3.4

—

Senile cataract

1145

3423

2.09

103.19

4.6

3.5

—

Osteopathies and chondropathies

1065

4873

2.07

103.10

4.7

3.4

—

Other retinal disorders

1263

5075

1.97

103.09

4.6

3.5

—

ILD medications: azathioprine

337

940

3.71

103.03

6.5

2.9

—

Unspecified haematuria

912

3475

2.23

102.97

4.3

3.7

—

Diseases of oesophagus, stomach and duodenum

1892

6509

1.76

102.78

4.0

3.4

—

Exclusions for E4_PCOS_BROAD

416

1328

3.25

102.77

5.1

3.8

—

Neurotic, stress-related and somatoform disorders

1518

5776

1.86

102.68

3.9

3.5

—

Depression or dysthymia

1186

3212

2.07

102.15

3.7

3.5

—

Selective serotonin reuptake inhibitors

1747

5085

1.81

101.97

3.4

3.5

—

GI-bleeding

744

3217

2.38

101.09

4.8

3.5

—

Anxiety (asthma-related co-morbidities)

971

3534

2.16

101.09

3.2

3.4

—

Asthma/COPD (KELA code 203)

1641

6298

1.81

100.66

4.2

3.3

—

Vocal cord dysfunction

230

427

4.95

100.33

4.6

2.8

—

Kela-code for severe mental illness

709

3008

2.41

100.23

3.9

3.4

—

Other cataract

852

2893

2.27

99.81

4.9

3.4

—

Other pleural conditions

290

751

4.06

99.38

5.4

3.2

—

Other diseases of intestines

1837

6015

1.76

98.33

3.8

3.4

—

Symptoms and signs involving the nervous and musculoskeletal systems

1102

5597

2.00

98.27

3.9

3.6

—

Unspecified mental disorder

759

3355

2.31

97.41

3.8

3.5

—

Pneumonia due to other infectious organisms, not elsewhere classified

136

184

8.13

96.49

6.2

3.5

—

Dental caries

554

2046

2.67

96.27

6.3

3.5

—

Atherosclerosis, excluding cerebral and coronary sclerosis

896

3319

2.19

96.03

5.3

3.6

—

Azathioprine

337

986

3.54

95.85

6.5

3.2

—

Diabetic retinopathy, excluding more controls

653

1439

2.64

95.03

5.3

3.2

—

Non-invasive ventilation

320

795

3.66

94.49

11.3

2.5

—

Caries of dentine

504

1816

2.78

94.48

6.4

3.5

—

Myocardial infarction, without ST-elevation

885

3825

2.16

94.24

4.9

3.7

—

Disorders of parathyroid gland

467

1654

2.88

93.69

6.5

3.2

—

Disorders of choroid and retina

1489

5905

1.82

93.35

4.5

3.5

—

Angina pectoris

993

3213

2.10

92.63

4.2

3.3

—

Nephrotic syndrome

141

210

7.48

92.11

8.2

2.9

—

Schizophrenia, schizotypal and delusional disorders

617

2559

2.47

91.86

3.9

3.5

—

Specific personality disorders

459

1652

2.85

91.31

3.5

—

Congenital malformations of the urinary system

192

386

5.33

91.18

8.1

4.1

—

Pneumocystosis

106

115

10.80

90.87

6.4

4.1

—

Abnormal findings on diagnostic imaging of lung

957

4559

2.05

90.46

4.9

3.6

—

Schizophrenia or delusion

613

2553

2.46

90.44

3.8

3.5

—

Streptococcal septicaemia

245

601

4.29

90.44

6.4

3.6

—

Cardiomyopathy

362

1148

3.25

90.36

5.0

2.9

—

Low back pain

1358

5348

1.85

90.07

3.7

3.5

—

Acute alcohol intoxication, ICD10

459

1669

2.84

89.91

3.8

—

Acute peritonitis

220

503

4.68

89.56

9.3

4.0

—

Myocardial infarction, strict

853

2835

2.18

89.52

4.8

3.3

—

Epilepsy

595

2456

2.47

88.81

3.8

3.5

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1118

5826

1.92

88.78

4.3

3.4

—

Preparatory care for dialysis

170

318

5.86

88.09

8.8

3.9

—

Acute upper respiratory infections

1791

6542

1.70

87.96

4.0

3.4

—

Emphysema

223

522

4.53

87.77

5.5

3.7

—

Paralytic ileus and intestinal obstruction

566

2306

2.52

87.76

3.9

3.6

—

Cystic kidney disease

137

209

7.26

87.40

8.2

3.5

—

Acidosis

102

111

10.42

86.73

7.4

3.2

—

Other anxiety disorders

765

3050

2.21

86.51

3.3

—

Other symptoms and signs involving the nervous and musculoskeletal systems

785

3694

2.17

86.43

4.0

3.6

—

Ulcer of lower limb, not elsewhere classified

374

1249

3.12

86.04

6.6

3.7

—

Falls/tendency to fall

1835

5461

1.70

85.16

3.7

3.5

—

Other disorders involving the immune mechanism, not elsewhere classified

134

206

7.20

84.88

7.8

3.6

—

Malignant neoplasm, wide definition for exclusion

1432

4710

1.80

84.49

3.6

—

Iron deficiency anaemia secondary to blood loss (chronic)

386

1325

3.02

84.33

4.9

3.4

—

Other or unspecified ileus, impaction or obstruction

438

1608

2.81

84.24

4.0

3.6

—

Hypothyroidism, strict autoimmune

1236

4399

1.87

84.01

3.9

3.2

—

Drug-induced adrenocortical insufficiency

109

10.50

83.76

5.8

3.3

—

Other endocrine disorders

173

324

5.46

83.52

3.9

—

Alcohol dependence

567

2367

2.46

83.52

3.9

—

Congenital malformations of the urinary system

192

416

4.91

83.38

8.1

3.9

—

Recurrent or chronic depression

629

1874

2.39

82.26

3.0

3.4

—

Acute alcohol intoxication

549

2276

2.47

82.11

4.0

3.9

—

Undetermined asthma, excluding more controls

212

501

4.34

81.40

4.0

2.4

—

Certain disorders involving the immune mechanism

417

1521

2.83

81.32

5.1

3.7

—

Osteoporosis

541

2082

2.50

81.09

4.6

3.5

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

629

2784

2.31

80.89

4.0

3.5

—

Other diseases of pericardium

141

238

6.34

80.85

5.6

3.3

—

Autoimmune diseases related-to ILD

1433

7129

1.74

80.49

3.8

3.4

—

Cystitis

1421

4804

1.78

80.40

3.8

3.4

—

All anxiety disorders

990

4051

1.96

79.87

3.3

3.4

—

Cystic kidney disease

137

229

6.56

79.85

8.2

3.7

—

Asthma, including avohilmo

2015

7058

1.62

79.82

3.7

3.5

—

Malignant neoplasm

1374

4595

1.79

79.23

3.6

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

196

450

4.58

78.90

3.4

3.3

—

Gastrointestinal diseases

918

2237

2.08

78.75

3.9

2.7

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

397

1436

2.86

78.70

3.2

3.7

—

Polycystic kidney disease

116

167

7.73

78.19

7.9

3.4

—

Bacterial pneumonia, not elsewhere classified

644

2547

2.26

77.68

5.4

2.8

—

Bacterial pneumonia (organism specified)

870

3995

2.01

77.27

5.5

3.3

—

Viral hepatitis, IBD co-morbidity

108

143

7.82

77.06

4.3

2.7

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

123

193

7.04

76.42

8.2

3.5

—

Cholelithiasis, broad definition with cholecystitis

1460

5764

1.72

76.16

3.7

3.5

—

Diseases of peritoneum

270

801

3.53

75.73

8.2

3.8

—

Disorders of thyroid, IBD co-morbidities

247

446

3.96

75.63

3.2

2.6

—

Cardiomyopathy (excluding other)

272

812

3.47

75.15

4.6

3.0

—

Cough

646

2806

2.21

74.81

3.7

3.4

—

Spondylosis

993

4309

1.91

74.53

3.3

3.7

—

Fluid overload

56.86

74.48

12.2

2.0

—

Cardiomyopathies, Primary/intrinsic

264

778

3.51

74.45

4.7

3.0

—

Non-allergic asthma (mode), excluding more controls

273

809

3.41

74.39

4.6

2.5

—

Sequelae with surgical and medical care as external cause

446

1762

2.61

74.27

4.3

3.6

—

Sequelae of external causes of morbidity and mortality

529

2263

2.40

73.89

4.4

3.6

—

Persons encountering health services for specific procedures, not carried out

201

494

4.24

73.86

4.5

2.9

—

Alcohol abuse, main dg, excluding more controls

305

989

3.18

73.43

4.1

3.8

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1641

6842

1.65

73.29

3.7

3.6

—

Intestinal stricture

631

2919

2.21

73.00

4.1

3.6

—

Other disorders of bladder

298

960

3.23

72.99

3.8

—

IgA nephropathy (IgA glomerulonephritis)

109

159

7.67

72.70

8.6

3.3

—

Cholelithiasis

1392

5659

1.71

71.61

3.7

3.5

—

Idiopathic pulmonary fibrosis

236

668

3.74

71.55

5.9

3.9

—

Drug-induced neutropenia

199

501

4.20

71.22

3.8

3.9

—

Other disorders of skin and subcutaneous tissue

1207

6174

1.76

71.02

4.8

3.4

—

Coagulation defects, purpura and other haemorrhagic conditions

415

1618

2.64

70.96

4.8

3.6

—

Cutaneous abscess, furuncle and carbuncle

497

2104

2.42

70.93

5.2

3.5

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1013

5568

1.84

70.87

4.4

3.4

—

Other/unspecified cytomegaloviral diseases

111

9.27

70.86

9.8

2.7

—

Hyperparathyroidism

390

1459

2.72

70.66

7.1

3.2

—

Emotionally unstable personality disorder

248

734

3.48

69.36

3.8

3.1

—

Undetermined asthma

212

564

3.85

69.29

4.0

2.6

—

Secondary right heart disease

143

284

5.43

69.12

6.6

3.7

—

Other pulmonary heart/vessel disease

154

326

5.07

69.05

6.5

4.0

—

Asthma, hospital admissions , main diagnosis only

1380

7319

1.68

68.99

3.8

3.5

—

Noninfective enteritis and colitis

817

4240

1.95

68.39

3.7

—

External causes of morbidity and mortality

1051

2830

1.88

68.33

3.7

3.4

—

Cardiodefibrillation

727

3632

2.04

68.23

4.2

3.8

—

Other and unspecified nonorganic psychotic disorders

366

1365

2.75

68.18

3.5

3.6

—

Type of accident

564

2564

2.25

68.09

4.0

3.5

—

Purpura and other haemorrhagic conditions

312

1075

3.01

67.88

4.4

3.8

—

Diabetic retinopathy, strict definition

497

1890

2.43

67.73

6.0

3.8

—

Protozoal diseases

115

191

6.61

67.55

6.4

4.0

—

Acute pancreatitis

404

1593

2.61

67.45

4.4

3.7

—

Other ill-defined and unspecified causes of mortality

238

704

3.57

67.43

5.2

4.1

—

Other external causes of accidental injury

1320

3828

1.74

67.41

3.7

3.4

—

Ill-defined and unknown causes of mortality

254

785

3.41

67.03

5.2

4.0

—

Abnormal results of function studies

218

609

3.74

67.01

4.7

3.8

—

Peripheral arterial reconstruction

405

1608

2.61

66.96

5.8

3.8

—

Finngen Rheumatological endpoints

1563

5445

1.65

66.88

3.8

3.3

—

Agranulocytosis

263

829

3.30

66.83

4.3

3.6

—

Chronic apical periodontitis

1844

6707

1.58

66.50

3.8

3.4

—

Pneumonitis due to solids and liquids

238

709

3.52

66.50

4.7

3.8

—

Mental and behavioural disorders due to opioids

119

207

6.13

66.18

4.7

3.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1521

6139

1.64

65.96

3.8

3.5

—

ILD-related respiratory insufficiency

132

257

5.65

65.65

9.3

4.0

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

112

185

6.44

65.61

6.4

2.8

—

Dysphagia

459

1947

2.41

65.25

4.9

3.6

—

Cytomegalovirus infection, IBD co-morbidity

137

7.79

65.24

9.4

2.8

—

Delirium, not induced by alcohol and other psychoactive substances

314

1109

2.94

65.24

4.6

3.9

—

Viral and other specified intestinal infections

478

1985

2.36

65.01

5.3

3.2

—

Diseases of the myoneural junction and muscle

296

1016

3.03

64.98

4.2

3.9

—

Accidents

1307

3828

1.73

64.50

3.7

3.4

—

Hypotension

406

1646

2.55

64.21

4.1

3.7

—

Viral and other specified intestinal infections

389

1500

2.58

64.11

5.8

3.2

—

Hypothyroidism, other/unspecified

1469

5940

1.64

63.94

3.8

3.5

—

Solid cancers, helper endpoint

1297

4530

1.71

63.90

3.5

3.6

—

Enlarged lymph nodes

277

925

3.07

63.30

3.5

3.2

—

Cellulitis

437

1842

2.43

63.16

5.4

3.5

—

Dorsalgia

1642

5515

1.61

63.14

3.4

3.5

—

Cytomegaloviral disease

142

7.47

63.09

9.4

2.7

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

339

1224

2.76

63.05

6.2

3.8

—

Symptoms and signs concerning food and fluid intake

215

620

3.58

62.54

4.8

3.3

—

Ascites

188

499

3.94

62.34

4.0

—

Chronic pancreatitis

281

959

3.04

62.27

4.6

3.8

—

Other CVD

447

1919

2.40

62.20

4.2

3.6

—

Diabetic maculopathy

379

1432

2.62

61.35

5.9

3.8

—

Second line medication for Crohn's disease

940

5283

1.80

61.29

4.6

3.5

—

Pain (limb, back, neck, head abdominally)

1197

3473

1.74

61.15

3.7

3.5

—

Dependence on enabling machines and devices, not elsewhere classified

13.42

61.08

9.7

2.7

—

Other obstructive and reflux uropathy

116

212

5.77

61.07

5.1

2.5

—

L04AX Other immunosuppressants

920

5145

1.81

61.02

4.6

3.5

—

Mental and behavioural disorders due to sedatives or hypnotics

171

431

4.15

60.93

4.4

3.5

—

Diseases of the skin and subcutaneous tissue

1640

5184

1.60

60.83

3.9

3.2

—

Thrombocytopenia, unspecified

200

565

3.73

60.75

4.9

3.9

—

Hypercalcemia

141

310

4.89

60.50

4.8

4.1

—

Any event in cancer register

1417

5126

1.64

60.47

3.5

3.6

—

Disorders of the thyroid gland

1555

6401

1.60

60.32

3.8

3.5

—

Injuries to the thorax

834

4549

1.86

60.20

4.0

3.7

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

349

1313

2.65

60.01

6.1

3.8

—

All influenza (not pneumonia)

267

901

3.04

59.97

5.6

3.0

—

Spondylopathies

1326

4814

1.66

59.35

3.4

3.6

—

Non-allergic asthma (mode)

273

929

2.96

59.02

4.6

2.6

—

Other noninfective gastroenteritis and colitis

467

2088

2.28

58.69

3.8

3.7

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

332

1281

2.68

58.32

4.0

—

Open wound of head

954

5263

1.77

58.20

4.0

3.6

—

Tubulo-interstitial nephritis, not specified as acute or chronic

147

344

4.44

57.65

4.8

2.6

—

Cerebrovascular diseases

1257

5383

1.66

57.64

4.1

3.7

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

143

330

4.61

57.60

5.3

3.8

—

Dermatitis

1023

5976

1.73

57.54

4.5

3.5

—

Other disorders of glucose regulation and pancreatic internal secretion

209

628

3.47

57.49

5.5

3.7

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1569

6435

1.58

57.41

4.2

3.5

—

Failure and rejection of transplanted organs and tissues

10.35

57.35

10.1

2.7

—

Factors influencing health status and contact with health services

487

1043

2.37

57.20

4.1

2.7

—

Abnormal findings on examination of urine, without diagnosis

136

305

4.75

56.82

5.9

3.8

—

Neoplasms

1168

3649

1.71

56.82

3.9

3.3

—

Other and unspecified myopathies

222

699

3.32

56.74

3.9

—

Pure hypercholesterolaemia

1087

4168

1.72

56.23

3.8

3.3

—

Acute sinusitis

782

3935

1.86

56.22

3.9

3.2

—

Chronic tubulo-interstitial nephritis

159

6.37

55.98

6.9

2.4

—

Lower back pain or/and sciatica

1698

7285

1.54

55.64

3.6

3.5

—

Unspecified fall

880

4930

1.78

55.23

3.9

3.7

—

Artificial opening status

143

341

4.42

55.07

6.2

3.7

—

Statin medication

1030

3345

1.75

54.73

4.2

2.9

—

Cardiac arrest

123

213

5.09

54.41

5.0

2.1

—

Other diseases of liver

348

1420

2.52

54.18

4.3

3.6

—

Acute pancreatitis (for exclusion)

404

1763

2.35

54.12

4.4

3.8

—

Respiratory conditions due to other external agents

124

7.39

54.08

4.1

3.5

—

Emotional disorders starting during childhood or adolecense, excluding more controls

100

172

5.89

54.00

4.0

3.1

—

Stroke, excluding SAH

1054

4568

1.71

53.93

4.0

3.7

—

Status epilepticus

113

227

5.30

53.81

5.7

3.4

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1323

5605

1.61

53.46

3.8

3.4

—

Gastroduodenal ulcer

527

2564

2.09

53.20

4.7

3.6

—

Stroke, including SAH

1093

4773

1.68

53.00

4.1

3.7

—

Calcific aortic valvular stenosis, operated

610

3043

1.99

52.86

4.5

3.7

—

Calcific aortic valvular stenosis

610

3043

1.99

52.86

4.5

3.7

—

Other specified and unspecified personality disorders

193

581

3.44

52.83

4.2

3.4

—

Diseases of pulp and periapical tissues, including avohilmo

1687

5740

1.53

52.74

3.5

—

Operations 2 for CAVS

609

3039

1.99

52.72

4.5

3.7

—

Calcific aortic valvular stenosis, diagnosis (helper)

609

3039

1.99

52.72

4.5

3.7

—

Calcific aortic valvular stenosis, including rheumatic fever

611

3056

1.98

52.39

4.5

3.7

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

331

1176

2.55

52.37

3.2

—

Other and unspecified effects of external causes

466

2181

2.18

52.35

4.0

3.5

—

Other bacterial intestinal infections

362

1528

2.43

52.32

6.0

3.3

—

Suppurative and necrotic conditions of lower respiratory tract

164

450

3.86

52.19

6.2

3.9

—

Other viral diseases

490

2333

2.13

52.17

5.9

3.4

—

Isolated proteinuria with specified morphological lesion

10.93

51.61

8.0

2.6

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

224

750

3.10

51.45

4.4

4.0

—

Other arthritis (FG)

523

2577

2.06

51.25

4.6

3.4

—

Diseases of the eye and adnexa

1235

3797

1.64

51.02

3.9

3.2

—

Malignant neoplasm of urinary organs

215

708

3.15

50.85

4.4

4.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

470

2237

2.15

50.83

4.3

3.7

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

697

3754

1.87

50.69

4.0

3.6

—

Ischaemic Stroke, excluding all haemorrhages

997

4419

1.70

50.68

4.0

3.7

—

Enterocolitis due to Clostridium difficile

250

897

2.89

50.67

6.6

3.6

—

Other neurological diseases

1205

5942

1.61

50.17

3.7

3.6

—

Malignant neoplasm of bronchus and lung, including Hilmo

417

1572

2.27

50.02

3.9

3.8

—

Non-selective monoamine reuptake inhibitors

587

2921

1.96

49.95

4.1

3.4

—

Other infectious diseases

217

728

3.10

49.76

5.3

3.8

—

Mixed and other personality disorders

170

492

3.58

49.53

4.2

3.3

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

161

451

3.72

49.39

4.1

3.7

—

Sulfonylureas

637

2683

1.92

48.91

4.4

3.7

—

Endocarditis

186

5.52

48.62

6.1

2.9

—

Schizophrenia

295

1173

2.58

48.52

4.3

3.7

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

198

640

3.21

48.33

4.1

3.5

—

Congenital malformations, deformations and chromosomal abnormalities

881

4947

1.71

48.20

4.9

3.3

—

Hypocalcemia

150

6.28

48.14

5.4

3.4

—

Viral infections characterized by skin and mucous membrane lesions

692

3821

1.84

48.04

5.1

3.5

—

Alcohol abuse, main dg

305

1240

2.52

47.94

4.1

3.8

—

Elevated blood glucose level

198

645

3.19

47.81

5.3

3.9

—

Gastro-oesophageal reflux disease

1078

5770

1.63

47.74

3.8

3.5

—

Nonorganic sleeping disorders, excluding more controls

292

1167

2.55

47.32

3.4

—

Disorders of magnesium metabolism

14.79

47.25

3.9

3.4

—

Hyperkinetic disorders, excluding more controls

165

457

3.52

47.18

3.1

—

Other viral diseases

581

3031

1.93

47.10

5.3

3.3

—

Other and unspecified dermatitis

829

4853

1.73

47.09

4.5

3.5

—

Other infectious diseases

188

600

3.26

47.03

5.4

3.9

—

Malnutrition

133

6.58

46.99

4.5

4.1

—

Amputation

238

868

2.84

46.83

7.3

3.9

—

Motor neuron disease (with DMD)

7.66

46.42

5.4

3.9

—

Malignant neoplasm of kidney, except renal pelvis

194

635

3.17

46.42

4.3

4.0

—

Bipolar affective disorders

298

1214

2.50

46.42

3.7

3.5

—

Other/unspecified dorsalgia

619

3310

1.88

46.39

3.7

3.5

—

Aortic aneurysm

460

2207

2.09

46.15

4.0

3.6

—

Clear cell adenocarcinoma of kidney

123

301

4.33

45.95

3.7

3.8

—

Peripheral artery operations in Hilmo

277

1099

2.59

45.92

6.9

3.6

—

Malignant neoplasm of bladder, including Hilmo

264

1018

2.66

45.82

3.6

3.9

—

Other disorders of white blood cells

141

381

3.89

45.81

5.0

3.9

—

Obesity, other/unspecified

501

2530

2.01

45.81

3.8

3.2

—

Other specified/unspecified arthritis

460

2266

2.06

45.22

4.7

3.5

—

Secondary uncertain malignant neoplasm

256

985

2.67

45.21

3.7

—

Systemic connective tissue disorders

582

3113

1.90

44.99

4.0

3.5

—

Malignant neoplasm of digestive organs

621

2642

1.88

44.94

3.6

3.8

—

Bacterial intestinal infections, IBD co-morbidities

358

1609

2.28

44.80

6.0

3.5

—

Presbycusis

319

1354

2.40

44.73

3.6

3.7

—

Other and unspecified drugs and medicaments

191

635

3.12

44.53

3.9

3.7

—

Soft tissue disorders

1615

5616

1.49

44.31

3.5

—

Motor neuron disease

7.63

44.28

5.2

3.7

—

Diabetic retinopathy

792

2854

1.77

44.01

5.1

4.0

—

Vitreous haemorrhage

227

835

2.82

44.00

5.9

3.9

—

Gout due to impairment of renal function

9.49

43.97

7.6

3.0

—

Isolated proteinuria

182

5.37

43.74

6.3

3.0

—

Pyothorax

132

354

3.96

43.59

6.4

4.1

—

Malignant neoplasm of respiratory system and intrathoracic organs

393

1522

2.20

43.53

3.9

3.7

—

Secondary polycythaemia

158

5.76

43.34

3.9

3.8

—

Any operation in hilmo

20.00

43.31

2.2

1.8

—

Other metabolic disorders

217

783

2.84

43.30

3.7

3.1

—

Migraine

613

2703

1.86

43.07

2.9

3.4

—

Focal epilepsy

387

1828

2.16

42.66

3.8

—

Diseases of the musculoskeletal system and connective tissue

828

2404

1.74

42.58

3.9

3.1

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

190

647

3.06

42.58

5.4

3.7

—

Hernia of abdominal wall

761

4481

1.72

42.50

4.6

3.6

—

Eosinophilic disease (BM)

10.02

42.41

5.5

2.8

—

Pleural plaque

219

807

2.81

42.38

3.9

3.2

—

KRA_PSY_EATING, excluding more controls

124

319

3.95

42.36

3.3

2.7

—

Other bacterial intestinal infections

400

1920

2.12

42.28

5.7

3.2

—

Alcoholic liver disease

222

826

2.78

42.12

4.2

4.1

—

Arthropathies in other diseases classified elsewhere

104

240

4.59

41.96

7.0

3.5

—

Other symptoms and signs involving the digestive system and abdomen

261

1049

2.54

41.93

4.3

3.4

—

Osteoporosis with pathological fracture (FG)

160

497

3.35

41.89

4.4

3.1

—

Cerebral cysts

143

415

3.60

41.74

3.7

3.6

—

Charcot foot

7.37

41.40

9.5

3.2

—

Fracture of rib(s), sternum and thoracic spine

539

2893

1.90

41.36

3.7

3.6

—

Other diseases of biliary tract

184

632

3.01

40.50

4.5

3.8

—

Abnormal findings on examination of blood, without diagnosis

825

4601

1.67

40.46

4.7

3.7

—

Leisure time condition

334

1525

2.24

40.25

4.1

3.7

—

Valvular operations

237

929

2.61

40.22

5.3

3.0

—

Dizziness and giddiness

1164

6047

1.54

40.17

3.5

3.6

—

Nonischemic cardiomyopathy

191

672

2.93

40.09

4.9

3.7

—

Traumatic subdural haemorrhage

251

972

2.54

39.81

4.2

3.7

—

Nerve, nerve root and plexus disorders

1638

6992

1.45

39.74

3.6

3.5

—

Other complications of surgical and medical care, not elsewhere classified

191

676

2.91

39.73

4.4

3.4

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

272

1145

2.43

39.72

3.8

3.7

—

Postviral fatigue syndrome

12.53

39.66

1.2

1.6

—

Haemorrhage, not elsewhere classified

205

4.76

39.60

5.5

3.3

—

Duodenal ulcer

236

935

2.60

39.40

5.0

3.7

—

Cardiomyopathy, other and unspecified

148

455

3.36

39.28

5.7

2.9

—

Cirrhosis of liver, NAS

137

404

3.56

39.17

4.1

4.3

—

Hypoglycaemia, other or unspecified

156

498

3.25

39.04

4.8

3.9

—

Congenital malformations, deformations and chromosomal abnormalities

929

5397

1.60

38.93

4.8

3.3

—

Non-small cell lung cancer, including Hilmo

296

1223

2.34

38.92

3.8

—

Alcohol-induced chronic pancreatitis

156

500

3.26

38.91

4.4

4.0

—

Other sleep disorders

198

725

2.80

38.55

3.6

3.7

—

Other systemic involvement of connective tissue (FG)

405

1995

2.04

38.39

3.5

—

Ventral hernia

419

2124

2.01

38.22

4.8

3.6

—

Injury, poisoning and certain other consequences of external causes

786

2320

1.71

38.15

3.8

3.4

—

Type 1 diabetes, definitions combined

164

543

3.08

38.10

3.6

3.5

—

Pneumonia due to Streptococcus pneumoniae

228

4.44

38.07

5.2

3.4

—

Intestinal malabsorption

109

280

4.07

38.05

4.2

3.3

—

Unspecified acute lower respiratory infection

270

1157

2.39

37.86

5.5

3.6

—

Other dorsopathies, not elsewhere classified

1531

5534

1.46

37.75

3.5

—

Other specified disorders of kidney and ureter

210

4.65

37.70

7.0

3.3

—

Neuromuscular dysfunction of bladder

179

631

2.93

37.57

4.7

3.8

—

Dental pulpitis, including avohilmo

1309

5758

1.49

37.14

3.3

3.6

—

128

5.80

37.04

3.1

3.2

—

Malignant neoplasm of bladder

160

535

3.10

36.97

3.9

3.8

—

Type 1 diabetes, strict (exclude DM2)

163

550

3.03

36.67

3.6

—

Diverticular disease of intestine

1083

4520

1.54

36.50

4.0

3.6

—

Focal epilepsy, strict definition

353

1711

2.10

36.48

3.7

3.8

—

Post-traumatic stress disorder

137

420

3.34

36.42

3.1

2.8

—

Hypoparathyroidism

220

4.46

36.37

3.9

3.2

—

Noninfectious colitis NAS

251

1065

2.41

36.05

3.9

3.7

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

338

1622

2.13

35.89

3.8

—

Fibrosis and cirrhosis of liver

168

588

2.97

35.89

4.2

4.1

—

Other diseases of pancreas

173

615

2.91

35.88

4.4

3.9

—

Drug-induced hypoglycaemia without coma

7.14

35.86

6.8

3.9

—

Other diseases of blood and blood-forming organs

155

520

3.10

35.73

4.4

3.9

—

Collagenous colitis

181

660

2.83

35.72

3.8

3.9

—

Fentanyl

196

742

2.70

35.71

5.1

3.6

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

152

5.20

35.37

3.9

2.8

—

Combinations of oral blood glucose lowering drugs

443

2349

1.92

35.37

3.5

3.7

—

Polyneuropathies and other disorders of the peripheral nervous system

395

2019

2.00

35.32

5.5

3.7

—

Vascular disorders of the intestines

162

561

3.00

35.27

3.9

3.8

—

Schizoaffective disorder

148

486

3.14

35.26

3.9

3.5

—

Attention to artificial openings

104

274

3.99

35.15

6.5

3.2

—

Phlebitis and thrombophlebitis (not including DVT)

370

1850

2.04

35.11

4.6

3.6

—

Other headache syndromes

537

3021

1.79

35.05

3.5

3.4

—

Injuries to the hip and thigh

789

4448

1.63

35.03

3.8

3.6

—

Malignant neoplasm of bronchus and lung

339

1349

2.13

34.93

3.9

3.7

—

Emotional disorders and disorders of social functioning with onset specific to childhood

107

282

3.86

34.87

4.0

3.3

—

Injuries to the ankle and foot

1008

5902

1.53

34.64

3.7

3.5

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

9.80

34.37

7.9

2.1

—

Exclusions for E4_PCOS_CONSORTIUM

972

3940

1.56

34.12

3.6

3.4

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

391

1991

1.97

33.83

4.2

3.3

—

Unspecified contracted kidney

12.94

33.79

9.7

2.8

—

Idiopathic gout

209

844

2.56

33.76

5.7

3.8

—

Other and unspecified tonsillitis

456

2061

1.88

33.67

3.5

3.1

—

Dissociative [conversion] disorders

195

4.48

33.51

2.8

2.4

—

Other gastritis (incl. Duodenitis)

382

1966

1.98

33.42

4.3

3.6

—

Reimbursement for rheumatic diseases

839

5354

1.58

33.34

3.9

3.5

—

Drug-induced osteoporosis with pathological fracture

6.63

33.32

5.0

3.9

—

Amputation of toe

169

620

2.83

33.18

7.5

3.9

—

Mycoses

432

2321

1.89

33.16

5.4

3.5

—

Protein-energy malnutrition of moderate and mild degree

8.69

33.13

4.6

4.5

—

Unstable angina pectoris

582

2666

1.74

33.04

4.3

3.4

—

Acute and transient psychotic disorders

202

808

2.56

33.03

4.1

3.7

—

Mouth breathing

623

3720

1.69

33.02

3.7

3.8

—

Cholangitis (primary sclerosing, PSC)

137

448

3.17

33.02

4.7

3.7

—

Myocarditis

153

4.90

32.83

5.6

1.8

—

Non-Hodgkin lymphoma, all, including Hilmo

231

990

2.39

32.52

3.8

—

Osteomyelitis

149

517

3.00

32.42

7.2

4.1

—

Inflammatory bowel disease

480

2688

1.81

32.14

3.4

3.5

—

Hypopituitarism

142

481

3.05

32.11

4.8

3.7

—

Molar incisor enamel hypoplasia, with caries

10.16

31.67

14.6

3.4

—

Presence of cardiac and vascular implants and grafts

669

3025

1.66

31.57

4.2

3.5

—

Other degenerative diseases of the nervous system

393

1525

1.95

31.56

3.4

3.6

—

Open wound of lower leg

264

1213

2.22

31.46

4.5

3.7

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

7.86

31.44

5.5

2.3

—

Other hearing loss

486

2691

1.79

31.41

3.9

3.7

—

Ulcerative ileocolitis

242

3.97

31.12

3.2

3.7

—

Other diseases of oesophagus

190

763

2.56

30.94

3.8

3.7

—

Other and unspecified polyneuropathies, also in other diseases

343

1751

2.00

30.89

5.9

3.7

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

783

3948

1.58

30.88

3.9

3.3

—

Hypoplasia of dental enamel

8.86

30.76

15.1

5.6

—

Phobic anxiety disorders

192

774

2.52

30.69

2.9

3.1

—

Benign intracranial hypertension

9.44

30.64

3.2

1.7

—

Other and unspecified vasculitis limited to skin

152

4.91

30.61

5.7

3.5

—

Sensorineural hearing loss

1163

5447

1.46

30.60

3.6

3.8

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

6.58

30.50

4.8

2.6

—

Superficial injury of lower leg

381

2021

1.91

30.43

4.2

3.5

—

Hernia

1374

6554

1.41

30.35

3.9

3.5

—

Other blood glucose lowering drugs, excl. Insulins

268

1259

2.17

30.22

4.9

3.6

—

Mental and behavioural disorders due to cannabinoids

165

4.63

30.20

3.2

3.1

—

Dermatitis and eczema

1643

7463

1.37

30.02

4.2

3.4

—

Diseases of the ear and mastoid process

1708

6282

1.37

29.98

3.7

3.5

—

Other embolism and thrombosis

227

1003

2.31

29.81

4.7

3.6

—

Dorsopathies

1522

5570

1.40

29.77

3.5

—

Candidiasis

422

2328

1.84

29.77

4.7

3.4

—

Missing teeth due to accident, extraction or parodontitis

897

5629

1.52

29.73

4.1

3.6

—

Gastric ulcer

319

1609

2.02

29.69

4.4

3.6

—

Type 1 diabetes, strict definition, subgroup 1

122

395

3.15

29.61

3.3

3.5

—

Candidiasis

228

1013

2.30

29.53

5.7

3.4

—

Non-small cell lung cancer

194

797

2.48

29.53

4.0

3.8

—

Viral infections characterized by skin and mucous membrane lesions

1253

7600

1.42

29.28

4.2

3.5

—

Type 1 diabetes, strict definition

127

424

3.06

29.22

3.6

3.4

—

Crohn disease

215

938

2.34

29.06

2.8

3.8

—

Emotional disorders starting during childhood or adolescence

102

298

3.51

29.03

4.1

3.6

—

Multiple myeloma, including Hilmo

104

312

3.48

29.01

4.1

3.8

—

Other condition

244

1124

2.22

28.95

4.0

3.8

—

Cholecystectomy

1030

6103

1.47

28.83

3.5

3.6

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

177

710

2.54

28.77

3.9

3.0

—

Internal derangement of knee

554

3314

1.68

28.75

4.0

3.5

—

Nonalcoholic fatty liver disease

167

655

2.62

28.57

3.4

3.7

—

Use of disulfiram, acamprosate or naltrexone

161

621

2.66

28.53

3.5

4.0

—

Vasculitis limited to skin, not elsewhere classified

165

4.56

28.52

5.6

3.6

—

Pericarditis

190

4.22

28.44

6.4

2.9

—

Assault

210

915

2.34

28.44

4.4

3.5

—

Carrier of infectious disease

133

5.00

28.42

6.0

2.9

—

Acute pharyngitis

219

967

2.28

28.07

3.2

3.3

—

Abnormal findings on diagnostic imaging of other body structures

225

1017

2.26

28.00

4.1

3.5

—

Migraine without aura

226

1020

2.24

27.99

3.3

3.2

—

Disorders of refraction and accommodation

383

2082

1.86

27.98

4.4

3.5

—

Other viral diseases, not elsewhere classified

289

1434

2.04

27.90

6.3

3.6

—

Injuries to the knee and lower leg

1752

7263

1.35

27.77

3.8

3.5

—

Dilated cardiomyopathy

234

1081

2.22

27.75

4.2

4.0

—

Arterial embolism and thrombosis

130

456

2.95

27.73

5.3

3.8

—

L01XE Protein kinase inhibitors

118

394

3.12

27.60

4.8

4.0

—

Other diseases of intestine

242

1134

2.18

27.52

4.6

3.6

—

Personal history of certain other diseases

6.45

27.35

3.8

2.0

—

Fibromyalgia

134

481

2.85

27.21

3.1

2.8

—

Abdominal aortic aneurysm (AAA)

212

944

2.28

26.88

4.4

3.8

—

Thiazolidinediones

200

877

2.34

26.85

4.5

3.8

—

Conductive and sensorineural hearing loss

1187

5686

1.42

26.77

3.7

—

Intentional self-harm by sharp object

132

4.84

26.68

3.0

2.0

—

Adverse effects, not elsewhere classified

298

1524

1.99

26.66

4.0

3.5

—

Unspecified nephritic syndrome

145

4.69

26.61

7.4

3.0

—

Unspecified jaundice

104

329

3.27

26.56

4.0

4.4

—

Other viral diseases, not elsewhere classified

374

2048

1.84

26.56

5.4

3.4

—

Non-Hodgkin lymphoma, all

300

3.40

26.49

3.3

4.0

—

Primary adrenocortical insufficiency

7.59

26.33

4.5

2.5

—

Other and unspecified disorders of white blood cells

277

3.51

26.28

4.6

3.7

—

Eosinophilia

5.78

26.16

5.5

3.9

—

Mental retardation, excluding more controls

191

4.01

26.12

4.7

4.6

—

Simple and mucopurulent chronic bronchitis

263

3.55

26.10

5.7

4.2

—

Other disorders of ear

1339

6375

1.38

26.06

3.7

—

Symptoms and signs involving appearance and behaviour

8.28

25.98

4.3

2.4

—

Iron deficiency

123

4.92

25.95

2.2

2.8

—

Secondary and unspecified malignant neoplasm of lymph nodes

147

569

2.65

25.92

4.3

3.8

—

Decubitus ulcer and pressure area

134

497

2.79

25.83

6.5

3.6

—

Infective dermatitis

200

895

2.29

25.59

4.7

3.5

—

Other systemic involvement of connective tissue

412

2366

1.77

25.49

3.5

—

Immunodeficiencies

292

3.37

25.47

5.6

3.7

—

Organic, including symptomatic, mental disorders

818

3901

1.51

25.40

3.5

3.8

—

Arthropathies

1294

4722

1.40

25.36

3.9

3.4

—

Alcohol withdrawal state with delirium

145

565

2.65

25.35

3.5

4.1

—

Ulcerative colitis

365

2026

1.83

25.34

3.6

3.7

—

Other symptoms and signs involving the circulatory and respiratory systems

115

396

2.98

25.30

4.7

3.3

—

Secondary malignant neoplasm of other and unspecified sites

104

5.36

25.12

3.7

3.2

—

Fracture of shoulder and upper arm

546

3385

1.63

25.11

3.9

3.7

—

Lyme disease

2679

0.35

25.08

3.1

3.7

—

Bronchiectasis

140

538

2.68

25.08

5.5

3.5

—

Other spirochaetal diseases

2707

0.35

25.04

3.1

3.7

—

Crohn's disease NAS

120

426

2.90

25.04

3.0

3.8

—

Pleural plaque with presence of asbestos

173

738

2.43

25.01

3.9

4.1

—

Childhood asthma (age<16), excluding more controls

148

447

2.64

24.96

3.5

2.4

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

646

4136

1.56

24.96

4.2

3.4

—

Amputation of ankle bones

157

4.41

24.94

10.8

3.7

—

Gingival hyperplasia

239

3.63

24.75

8.4

4.1

—

Panic disorder

195

876

2.26

24.57

3.4

3.2

—

Fracture of lumbar spine and pelvis

364

2037

1.81

24.55

3.9

3.6

—

Spirochaetal infections, other/unspecified

2695

0.36

24.53

3.1

3.7

—

Other spirochaetal diseases

101

2751

0.36

24.47

3.1

3.7

—

Non-small cell lung cancer, adenocarcinoma

121

438

2.86

24.43

3.9

4.1

—

Amyloidosis

130

4.72

24.41

5.3

3.6

—

Psychotic depression

316

3.18

24.16

3.7

3.8

—

Necrosis of pulp, including avohilmo

781

5278

1.49

24.05

3.4

3.6

—

Multiple myeloma and malignant plasma cell neoplasms

109

377

3.01

24.05

4.1

4.2

—

Superficial injury of abdomen, lower back and pelvis

241

1188

2.06

24.01

3.8

3.6

—

Fracture of foot, except ankle

349

1946

1.82

23.90

4.3

3.6

—

Ulcerative colitis, NAS

220

1053

2.13

23.74

3.8

3.7

—

Childhood asthma (age<16)

148

460

2.56

23.63

3.5

2.6

—

Injuries to the shoulder and upper arm

1226

7247

1.37

23.41

3.7

3.6

—

Rheumatoid arthritis

459

2482

1.68

23.34

3.8

3.5

—

Coronary artery bypass grafting

405

1745

1.75

23.33

4.7

3.4

—

Diseases of pulp and periapical tissues and dental caries

998

3582

1.44

23.05

3.7

3.6

—

Abnormalities of gait and mobility

219

1061

2.11

23.03

3.5

4.1

—

Pneumothorax

127

486

2.69

22.99

5.6

3.4

—

Sulfasalazine

363

2071

1.77

22.96

3.7

3.1

—

Other joint disorders

1228

4711

1.38

22.95

3.4

—

Misadventures to patients during surgical and medical care

228

1121

2.07

22.94

5.0

3.4

—

Meniscus derangement

798

3651

1.48

22.92

3.5

—

Benign neoplasms

1449

5973

1.34

22.90

3.9

3.4

—

Pyogenic arthritis

125

476

2.70

22.84

5.6

3.4

—

Chronic viral hepatitis

330

3.06

22.55

4.4

3.3

—

Folate deficiency anaemia

7.43

22.50

5.3

3.7

—

Nonorganic sleeping disorders

292

1573

1.88

22.42

3.4

3.5

—

Maltreatment syndromes

317

3.08

22.19

3.4

2.8

—

Dental caries, including avohilmo

1107

4072

1.40

22.10

3.6

—

Open wound of ankle and foot

179

815

2.24

22.04

4.5

3.9

—

Systemic atrophies primarily affecting the central nervous system

320

3.09

21.99

4.4

4.0

—

Hyperaldosteronism

186

3.84

21.96

4.5

3.4

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

460

2834

1.64

21.90

3.9

3.6

—

Somatoform disorder

230

1154

2.02

21.84

4.0

3.4

—

Arterial embolism and thrombosis of lower extremity artery

259

3.34

21.83

4.5

3.8

—

Oesophageal varices

306

3.13

21.77

4.8

4.2

—

Superficial injury of hip and thigh

250

1294

1.97

21.75

4.1

3.6

—

Infection due to other mycobacteria

5.32

21.73

5.9

3.7

—

Disturbance of activity and attention

161

689

2.33

21.70

3.1

3.2

—

Thoracic aortic aneurysm

236

1203

2.00

21.55

4.0

3.7

—

Caries of dentine, including avohilmo

1165

4337

1.38

21.49

3.7

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

171

773

2.26

21.48

4.1

3.7

—

Viral warts

160

703

2.32

21.45

5.9

3.5

—

Urticaria and erythema

480

3003

1.61

21.42

3.9

3.5

—

Intestinal adhesions without obstruction

149

636

2.40

21.40

3.8

3.9

—

Behavioural syndromes associated with physiological disturbances and physical factors

1256

6636

1.35

21.31

3.1

3.6

—

Other diseases of anus and rectum

442

2709

1.65

21.31

3.7

3.6

—

Diffuse large B-cell lymphoma

294

3.14

21.26

3.9

3.7

—

Diffuse large B-cell lymphoma, helper endpoint

294

3.14

21.26

3.9

3.7

—

Diffuse large B-cell lymphoma, including Hilmo

294

3.14

21.26

3.9

3.7

—

Dental operations

928

3347

1.43

21.26

3.9

3.5

—

Vascular diseases of the intestine

284

3.18

21.23

3.6

3.8

—

Weight loss

177

818

2.22

21.07

4.1

4.0

—

Mixed disorders of conduct and emotions, excluding more controls

5.50

21.03

4.5

3.5

—

Other eating disorders

259

3.24

20.97

3.5

2.9

—

Periapical abscess

620

4129

1.52

20.96

3.5

3.7

—

DVT of lower extremities

292

1609

1.84

20.94

4.4

3.6

—

Allergic asthma (mode), excluding more controls

211

1016

2.05

20.93

2.9

2.4

—

Discitis, unspecified

105

4.87

20.91

5.5

3.9

—

5-aminosalicylic acid

274

1480

1.87

20.85

3.2

—

Persistent mood disorders

265

1418

1.89

20.81

4.6

3.5

—

Degeneration of macula and posterior pole

718

3901

1.48

20.79

3.7

—

Other renal tubulo-interstitial diseases

109

4.68

20.75

5.8

2.1

—

Fracture of femur

442

2473

1.64

20.72

3.9

3.7

—

Toxic effect of other and unspecified substances

6.27

20.70

4.7

3.1

—

Eating disorder

125

499

2.55

20.61

3.3

2.7

—

Left bundle-branch block

112

425

2.70

20.60

3.1

2.9

—

Zoster [herpes zoster]

290

1604

1.84

20.58

5.1

3.7

—

Continuous positive airway pressure

171

651

2.23

20.54

4.6

2.7

—

Vitamin deficiency

289

3.10

20.54

5.1

3.3

—

Vitamin deficiency, wide

289

3.10

20.54

5.1

3.3

—

Alcohol-induced acute pancreatitis

264

3.24

20.54

4.0

4.1

—

Other disorders starting during childhood or adolecense, excluding more controls

193

3.55

20.48

5.0

3.1

—

Zoster [herpes zoster]

692

4658

1.47

20.46

4.2

3.5

—

Somnolence, stupor and coma

317

3.00

20.43

6.0

3.6

—

FESS (DNB20)

190

913

2.12

20.40

3.8

3.5

—

Hepatic failure, not elsewhere classified

266

3.21

20.27

3.7

4.2

—

Superficial injury of thorax

237

1236

1.95

20.22

3.9

3.8

—

Renal agenesis and other reduction defects of kidney

9.34

20.18

10.5

3.4

—

Use of pramipexole

335

1944

1.75

20.16

4.1

3.6

—

Amyloidosis, other/unspecified

104

4.79

20.16

6.0

3.5

—

476

2620

1.60

20.10

3.8

3.6

—

Crohn's disease of large intestine

309

3.00

20.05

3.6

3.4

—

Total colectomy

278

3.13

20.03

4.4

3.5

—

Total colectomy operation

278

3.13

20.03

4.4

3.5

—

Malignant neoplasm of skin

656

3023

1.50

19.97

3.6

3.7

—

Gonarthrosis [arthrosis of knee](FG)

1028

4340

1.39

19.93

3.4

—

Glaucoma

823

5009

1.43

19.92

3.8

3.7

—

Fracture of lower leg, including ankle

754

5213

1.44

19.91

4.1

3.5

—

Sarcoidosis

206

1030

2.04

19.88

3.1

3.7

—

Secondary thrombocytopenia

5.75

19.83

5.2

4.0

—

Irritable bowel syndrome

352

2077

1.71

19.83

3.0

3.3

—

Generalized anxiety disorder

193

941

2.08

19.83

2.7

3.1

—

Other necrotizing vasculopathies

134

566

2.43

19.81

5.4

4.0

—

Other necrotizing vasculopathies (FG)

111

429

2.66

19.80

5.4

3.2

—

Other viral hepatitis

106

400

2.72

19.77

4.3

3.4

—

Other symptoms and signs involving the urinary system

175

826

2.16

19.75

4.4

4.1

—

Postprocedural disorders of digestive system, not elsewhere classified

200

3.54

19.66

5.4

3.6

—

Migraine with aura

261

1415

1.86

19.61

2.9

3.3

—

Methotrexate

190

926

2.08

19.60

2.9

3.1

—

Colorectal cancer

338

1936

1.73

19.58

3.7

—

Polyarteritis nodosa and related conditions

5.27

19.56

3.7

3.5

—

Urolithiasis

503

3256

1.56

19.53

3.7

3.8

—

Eating disorders

148

654

2.30

19.49

3.5

3.0

—

Other and unspecified mood [affective] disorders

102

380

2.74

19.44

3.4

3.0

—

Other Crohn's disease

112

439

2.61

19.35

2.9

3.4

—

Ethmoidectomy

194

959

2.06

19.32

3.8

3.6

—

Cholecystitis

223

1158

1.96

19.29

4.0

3.7

—

Radiculopathy

253

1370

1.88

19.24

3.8

3.5

—

ILD medications: nintedanib

8.01

19.20

8.3

2.7

—

152

3.94

19.13

7.9

4.1

—

Abnormal weight loss

162

753

2.20

19.08

3.8

3.9

—

Other abnormalities of plasma proteins

101

4.75

19.03

6.9

3.1

—

Postmenopausal osteoporosis with pathological fracture

110

432

2.62

19.02

4.1

3.3

—

Polycystic ovarian syndrome, consortium definition

821

3429

1.43

18.97

3.3

3.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

601

2756

1.51

18.83

3.8

3.7

—

Other aneurysm

109

429

2.62

18.79

4.8

3.9

—

Disorders of psychological development

175

776

2.12

18.76

3.8

3.6

—

Transport accidents

572

3284

1.51

18.72

3.3

3.4

—

Viral pneumonia (known virus, not influenza)

178

3.65

18.68

6.8

3.6

—

346

1941

1.70

18.68

4.0

3.6

—

Dermatographic urticaria

104

401

2.65

18.60

3.6

3.1

—

Adult respiratory distress syndrome

5.16

18.59

8.7

3.2

—

Hyperfunction of pituitary gland

255

3.10

18.28

4.6

2.4

—

Astigmatism

105

410

2.62

18.28

5.7

3.9

—

Other diseases of arteries and capillaries

146

662

2.25

18.26

5.7

3.6

—

Excessive vomiting in pregnancy

102

393

2.64

18.21

2.7

—

Colectomy operation

266

1490

1.81

18.19

3.9

3.7

—

severe traumatic brain injury, does not include concussion

359

2184

1.67

18.16

4.0

3.8

—

Arthrosis

977

3918

1.38

18.07

3.3

3.4

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

629

2906

1.48

18.00

3.9

3.7

—

Disorders of eyelid, lacrimal system and orbit

1190

6868

1.32

17.94

3.3

3.6

—

Rheumatism, unspecified

177

870

2.06

17.90

3.5

3.3

—

Hyperkinetic disorders

167

785

2.11

17.90

3.0

3.4

—

Respiratory disorders in diseases classified elsewhere

5.07

17.84

6.8

3.4

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

155

727

2.18

17.82

6.4

4.4

—

Toxic effects of substances chiefly nonmedicinal as to source

176

867

2.07

17.75

3.4

3.8

—

Sicca syndrome [Sjögren]

129

562

2.35

17.75

3.0

3.4

—

Chronic ulcer of skin, not elsewhere classified

126

545

2.37

17.69

6.1

3.6

—

Hyperosmolality and hypernatraemia

5.37

17.66

6.4

2.9

—

Traumatic subarachnoid haemorrhage

204

3.34

17.63

3.6

4.0

—

Pneumonia derived septicemia

251

3.10

17.62

6.3

3.5

—

Calculus of kidney and ureter

458

2974

1.56

17.61

3.9

3.8

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

121

516

2.42

17.60

3.9

4.0

—

Dermatitis due to substances taken internally

378

2.66

17.59

4.9

3.5

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

111

455

2.50

17.55

3.3

3.9

—

Intentional self-harm by unspecified means

5.62

17.54

3.3

2.1

—

Urticaria

377

2341

1.63

17.49

3.9

3.5

—

Lung transplant status

6.99

17.47

11.7

3.8

—

Lung transplantation

6.98

17.46

11.8

3.8

—

Pneumonia due to Haemophilus influenzae

16.46

17.43

5.4

2.3

—

Gonarthrosis

890

3677

1.39

17.42

3.4

3.5

—

Superficial injury of head

333

2008

1.68

17.39

3.6

—

Maternal care for other conditions predominantly related to pregnancy

217

1132

1.90

17.33

2.4

2.6

—

Open wound of forearm

157

749

2.14

17.29

4.2

3.6

—

Other follicular disorders

114

476

2.45

17.28

5.3

3.3

—

Unknown and unspecified causes of morbidity

364

2.66

17.18

4.8

3.0

—

Speech disturbances, not elsewhere classified

158

759

2.13

17.15

4.1

3.8

—

Aortic valve malfunction, age under 60 years

144

667

2.20

17.12

6.4

4.3

—

ILD medications: pirfenidone

5.59

17.11

6.7

2.5

—

Other disorders of lacrimal gland

461

3017

1.54

17.07

3.4

3.6

—

Panhypopituitarism

110

4.31

17.05

3.4

3.5

—

Pain in joint

717

3219

1.43

16.99

3.7

3.6

—

Acute posthaemorrhagic anaemia

220

3.20

16.90

6.2

3.6

—

Mixed hyperlipidaemia

257

3.01

16.88

4.7

3.6

—

Allergic asthma (mode)

211

1098

1.89

16.85

2.9

2.5

—

Suppurative and unspecified otitis media

450

2596

1.55

16.73

4.2

3.3

—

Blood alcohol or alcohol intoxication level

157

3.65

16.72

3.3

2.9

—

Renal agenesis and other reduction defects of kidney

7.31

16.63

10.5

3.1

—

Other problems related to primary support group, including family circumstances

148

680

2.15

16.59

6.3

3.3

—

Spondyloarthritis

251

1421

1.79

16.53

4.0

3.6

—

Mental retardation

264

2.95

16.48

4.7

4.2

—

Inflammatory diseases of female pelvic organs

677

3505

1.43

16.45

3.4

3.0

—

Use of biperiden

356

2.66

16.44

3.9

3.7

—

Abscess of lung

4.52

16.44

7.0

2.8

—

Non-follicular lymphoma

165

819

2.06

16.43

3.8

4.1

—

Other obstetric conditions, not elsewhere classified

320

1207

1.70

16.41

2.2

2.4

—

Testicular dysfunction

241

3.05

16.28

3.9

—

Other or ill-defined heart diseases

289

2.83

16.26

4.5

2.9

—

Acute drug-induced interstitial lung disorder

6.70

16.26

4.1

2.9

—

Other abnormal findings in urine

102

4.36

16.09

5.1

3.9

—

Sequelae of cerebrovascular disease

539

3170

1.48

16.08

3.9

3.7

—

Other abnormal findings of blood chemistry

320

2.74

16.08

4.0

—

Myalgia

291

1730

1.70

16.07

3.1

3.5

—

Unspecified chronic bronchitis

216

3.15

16.07

5.0

4.0

—

Congenital malformations of cardiac septa

104

416

2.47

16.06

4.4

4.5

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

323

1976

1.66

16.05

4.0

3.4

—

Deforming dorsopathies

368

2323

1.60

16.02

3.4

3.6

—

Injury of nerves and spinal cord at neck level

138

3.79

16.01

3.4

3.8

—

Right bundle-branch block

202

3.21

15.89

4.3

3.2

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1012

3836

1.34

15.86

3.8

3.5

—

Spinal stenosis

718

3912

1.40

15.85

3.5

3.7

—

Wide developmental disorders, excluding more controls

122

3.88

15.84

2.6

3.5

—

Sleep disorders

1158

6443

1.30

15.81

2.9

3.6

—

Other symptoms and signs involving cognitive functions and awareness

661

4282

1.42

15.76

3.7

—

IBD patients in KELA-register

299

1801

1.68

15.75

3.1

3.6

—

Transient ischemic attack

736

4309

1.39

15.66

3.7

—

Umbilical hernia

393

2534

1.57

15.66

4.6

3.7

—

Pneumococcal septicemia

247

2.98

15.63

6.4

3.7

—

Disorders of lacrimal system

553

3814

1.46

15.62

3.3

3.6

—

Viral hepatitis

111

480

2.36

15.60

4.3

3.4

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

311

1179

1.69

15.59

2.2

2.4

—

6.78

15.57

4.4

1.6

—

Colorectal adenocarcinoma

278

1645

1.71

15.56

3.6

3.7

—

Corticotropin deficiency

6.35

15.54

4.3

2.6

—

Mixed specific developmental disorders

111

3.98

15.53

5.0

6.0

—

Disorders of sclera, cornea, iris and ciliary body

727

5280

1.39

15.52

4.1

3.5

—

Disorders of oesophagus in diseases classified elsewhere

132

3.81

15.47

5.1

3.8

—

Smoking dependency

132

616

2.19

15.45

5.2

3.8

—

Diseases of male genital organs

795

2905

1.39

15.45

4.1

3.9

—

Impotence

102

428

2.45

15.44

5.3

4.2

—

Benign neoplasm of other and unspecified endocrine glands

194

1039

1.90

15.43

3.7

3.8

—

Acute suppurative otitis media

318

1820

1.64

15.41

4.5

3.3

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

142

3.69

15.39

6.6

3.5

—

Focal brain injury

379

2.53

15.38

3.2

3.9

—

Acute laryngitis and tracheitis

147

702

2.08

15.37

4.1

3.2

—

Biological medicines for asthma

101

4.24

15.35

3.7

2.7

—

Testicular hypofunction

212

3.13

15.34

4.1

3.7

—

Type1 diabetes, definitions combined, early onset

101

420

2.44

15.34

3.4

3.7

—

Mental and behavioural disorders due to tobacco

132

618

2.18

15.33

5.2

3.8

—

Mental retardation, wide definition

281

2.81

15.27

4.6

4.4

—

Drug-induced osteoporosis

5.08

15.20

3.9

2.6

—

Seropositive rheumatoid arthritis

321

1979

1.63

15.19

4.3

3.5

—

Colitis, primary sclerosing

5.03

15.15

3.9

2.8

—

Other ulcerative colitis

377

2.53

15.11

4.3

3.7

—

Diseases of middle ear and mastoid

732

4355

1.38

15.04

4.1

3.3

—

Atypical mycobacterium lung infection

4.90

14.97

6.6

2.7

—

Rash and other nonspecific skin eruption

148

731

2.06

14.93

4.3

3.8

—

Chronic periodontitis, complicated

736

5343

1.37

14.91

4.3

3.7

—

Complications following infusion, transfusion and therapeutic injection

4.40

14.82

4.6

2.6

—

Injuries to the neck

305

1877

1.64

14.81

3.3

3.6

—

Colitis, primary sclerosing, strict definition

5.95

14.81

2.7

3.0

—

Abnormal findings on diagnostic imaging of central nervous system

282

2.76

14.78

3.9

3.7

—

Glaucoma suspect

493

3375

1.47

14.77

3.9

3.7

—

Heart failure and hypertrophic cardiomyopathy

132

3.76

14.76

6.9

3.5

—

Generalized skin eruption due to drugs and medicaments

233

2.96

14.73

4.6

3.7

—

Mucosal proctocolitis

175

920

1.93

14.72

3.2

3.7

—

Polyarthrosis

269

1487

1.70

14.70

3.8

3.7

—

Speech and linguistic disorders, excluding more controls

379

2.44

14.69

3.9

3.5

—

Functional dyspepsia

343

2176

1.59

14.67

3.6

3.4

—

Irregular menses

496

2668

1.48

14.63

3.2

2.9

—

Papilloedema, unspecified

123

3.80

14.60

4.4

2.5

—

Immunodeficiency with predominantly antibody defects

152

3.48

14.54

6.6

3.1

—

Cushing syndrome

5.30

14.53

3.5

1.8

—

Carcinoma in situ of skin of other and unspecified parts of face

149

748

2.04

14.46

4.8

3.8

—

Other disorders of nervous system

113

510

2.27

14.45

4.0

4.1

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

350

2.55

14.42

3.4

4.0

—

Appendectomy

815

5824

1.35

14.38

3.5

—

Autism spe, excluding more controls

4.40

14.37

1.6

3.0

—

Status post-ami

363

1771

1.58

14.37

4.0

3.4

—

Syndrome of inappropriate secretion of antidiuretic hormone

7.40

14.35

2.7

2.5

—

Scabies

310

2.65

14.31

5.4

3.4

—

Septal defects

402

2.41

14.29

4.2

4.4

—

Asthma mixed form (mode), excluding more controls

183

3.16

14.27

2.4

—

Hypertrophy of (infrapatellar) fat pad

5.73

14.21

4.7

2.3

—

In situ neoplasms

515

3582

1.45

14.20

4.4

3.5

—

Other diseases of spinal cord

206

3.07

14.18

6.3

4.0

—

Outcome of delivery

671

0.24

14.08

1.7

2.9

—

Other and unspecified glaucoma

120

561

2.19

14.07

3.1

3.9

—

Inflammatory bowel disease, strict (require KELA)

299

1856

1.63

14.05

3.1

3.6

—

Abnormal blood-pressure reading, without diagnosis

217

2.97

14.04

2.6

3.2

—

Migraine without aura and triptan purchases

180

969

1.88

14.04

3.0

—

Other diseases of stomach and duodenum

107

478

2.29

14.02

5.6

3.8

—

Personal history of other diseases and conditions

127

603

2.12

14.01

3.6

2.5

—

Disorders of muscles

143

716

2.03

13.90

4.1

3.7

—

Myocardial infarction, unclassifiable

365

2118

1.56

13.88

4.6

3.8

—

Biological medication for rheuma

213

1215

1.77

13.77

2.7

3.6

—

Hodgkin lymphoma, hilmo

173

3.23

13.73

5.5

3.5

—

Parkinson's disease, excluding more controls

174

878

1.89

13.70

3.5

3.7

—

Asthma and allergy, excluding more controls

111

499

2.21

13.68

2.6

2.5

—

Necrotizing fasciitis

12.38

13.49

4.1

3.8

—

Other factor of the environment

4.81

13.49

3.7

2.4

—

Special screening examination for infectious and parasitic diseases

1405

0.43

13.48

3.9

2.9

—

Psoriatic and enteropathic arthropathies

155

808

1.95

13.42

3.0

3.2

—

Drug-induced cataract

146

3.42

13.31

7.6

3.0

—

Osteonecrosis

438

2.31

13.31

6.0

3.8

—

Crohn's disease of small intestine

431

2.32

13.31

2.9

3.6

—

Fitting and adjustment of external prosthetic device

14.86

13.31

16.2

1.7

—

Schizotypal disorder

136

3.50

13.30

2.1

3.1

—

Disorders of skin appendages

594

4284

1.39

13.22

4.2

3.4

—

Disorder of lipoprotein metabolism, unspecified

182

1005

1.84

13.19

4.8

3.6

—

Kyphosis

4.37

13.17

3.8

—

Lichen simplex chronicus and prurigo

102

459

2.27

13.17

6.2

3.5

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

698

5028

1.36

13.11

3.6

3.7

—

Brachial plexus disorders

118

563

2.13

13.08

2.7

3.3

—

Other immunodeficiencies

5.28

13.07

3.5

2.5

—

Symptoms and signs involving speech and voice

433

2963

1.47

13.06

3.6

3.5

—

Otitis media, unspecified

152

728

1.95

13.06

5.6

3.2

—

Budesonide

171

930

1.86

12.99

3.7

3.2

—

Malignant neoplasm of brain, including Hilmo

303

2.57

12.85

3.1

3.6

—

Abnormal involuntary movements

185

1036

1.81

12.82

3.7

3.9

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

435

2974

1.47

12.81

3.3

3.4

—

Amenorrhoea

346

2.43

12.70

3.4

2.8

—

Sequelae of injuries, of poisoning and of other consequences of external causes

306

1959

1.58

12.69

3.4

3.6

—

Other disorders of veins

493

3454

1.43

12.68

4.4

3.4

—

Redundant prepuce, phimosis and paraphimosis

296

1862

1.59

12.67

3.7

3.9

—

Pure hyperglyceridaemia

116

3.66

12.67

3.4

3.5

—

Pulmonary oedema

131

3.51

12.65

6.5

3.9

—

Injuries to the elbow and forearm

909

6171

1.30

12.64

3.9

3.5

—

Vitamin D deficiency

3.93

12.59

3.9

3.0

—

Basal cell carcinoma, including avohilmo

560

2758

1.41

12.58

3.6

3.7

—

Injuries to unspecified part of trunk, limb or body region

153

813

1.91

12.58

4.5

3.9

—

Other (seronegative) rheumatoid arthritis, wide

256

1575

1.64

12.57

3.7

3.6

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

117

3.64

12.54

3.0

3.7

—

Monoamine oxidase A inhibitors

153

813

1.91

12.54

4.4

3.5

—

Disorders of parathyroid gland, other and/or unspecified

5.57

12.50

7.7

2.6

—

Acute generalized exanthematous pustulosis

278

2.62

12.49

4.6

3.7

—

Personal history of risk-factors, not elsewhere classified

4.87

12.49

3.5

2.6

—

Faecal incontinence

116

561

2.10

12.44

3.9

3.5

—

Diastasis of muscle

6.13

12.43

2.4

2.7

—

Dissocial personality disorder

4.06

12.43

4.3

3.5

—

Late syphilis

4.17

12.40

10.1

3.3

—

Familial hypercholesterolemia

205

1198

1.73

12.26

3.5

3.6

—

Thyrotoxicosis, other and/or unspecified

241

1469

1.66

12.26

3.1

3.4

—

Rheumatoid arthritis, including avohilmo

488

3456

1.42

12.26

3.8

3.6

—

Anorexia (incl.atypical)

346

2.41

12.24

4.0

3.4

—

Diseases of oral cavity, salivary glands and jaws

865

3390

1.32

12.21

3.8

3.5

—

Other coagulation defects

107

506

2.15

12.21

5.6

3.7

—

Pediculosis, acariasis and other infestations

416

2.28

12.20

5.1

3.6

—

Hypermetropia

103

480

2.18

12.17

5.7

3.9

—

Other inflammatory liver diseases

100

462

2.21

12.13

5.3

4.0

—

Paracetamol or NSAID medication

228

667

1.73

12.11

3.7

4.1

—

Previous suicide attempt

5.26

12.10

3.5

2.6

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

185

1053

1.78

12.06

4.6

3.6

—

Other and unspecified local infections of skin and subcutaneous tissue

137

712

1.96

12.06

6.4

3.7

—

Scoliosis

114

555

2.09

12.03

4.1

3.5

—

Disorders of plasma-protein metabolism, not elsewhere classified

10.39

12.01

2.3

2.9

—

Prurigo nodularis

156

3.19

11.98

7.0

3.2

—

Otitis externa, unspecified

154

834

1.87

11.94

4.9

3.8

—

Abnormality of white blood cells, not elsewhere classified

5.45

11.94

6.8

3.0

—

Insomnia

1094

6325

1.27

11.93

2.8

3.5

—

Asthma and allergy

111

528

2.09

11.92

2.6

—

Late syphilis

107

3.72

11.91

9.2

3.1

—

Herpesviral [herpes simplex] infections

156

849

1.86

11.91

5.1

3.4

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

320

2.44

11.90

4.8

3.7

—

Malignant neoplasm of colon, including Hilmo

251

1558

1.63

11.87

3.3

3.7

—

Malignant neoplasm of colon

202

1187

1.72

11.86

3.5

3.7

—

Other and unspecified diseases of blood and blood-forming organs

157

3.16

11.84

5.5

3.4

—

Malignant neoplasm of small intestine

117

3.55

11.80

4.9

3.3

—

Other fall from one level to another

299

1938

1.56

11.76

3.3

3.9

—

Habit and impulse disorders

4.23

11.71

1.9

2.0

—

Acute lymphadenitis

355

2.35

11.61

4.8

3.5

—

Manic episode

180

2.97

11.60

5.5

3.3

—

Squamous cell neoplasms and carcinomas of the skin

128

659

1.98

11.59

5.1

3.9

—

Sciatica+with lumbago

632

4326

1.35

11.59

3.2

3.6

—

Hypoplasia of dental enamel , including avohilmo

169

3.01

11.57

13.1

3.3

—

Patent foramen ovale

144

3.25

11.54

4.9

4.7

—

Mild mental retardation

165

3.07

11.52

4.3

3.7

—

Cardiomyopathy, Hypertrophic obstructive

3.98

11.49

8.3

3.4

—

Other specified/unspecified soft tissue disorders

302

2.47

11.46

4.0

3.5

—

Mixed disorders of conduct and emotions

124

3.40

11.46

4.5

3.3

—

Basal cell carcinoma

535

2672

1.39

11.43

3.7

—

Other local infections of skin and subcutaneous tissue

144

775

1.89

11.42

6.2

3.6

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

126

509

2.00

11.42

3.5

3.8

—

Congenital malformations of the circulatory system

190

1076

1.73

11.39

5.0

4.0

—

Pre-eclampsia or poor fetal growth

293

1897

1.55

11.37

3.4

2.7

—

Other misadventures during surgical and medical care

156

3.13

11.35

4.5

3.2

—

Malignant neoplasm of rectum, including Hilmo

166

936

1.80

11.31

3.7

—

Mesothelioma, including Hilmo

4.26

11.30

3.1

4.1

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

106

3.63

11.28

4.5

3.2

—

Wegener granulomatosis

3.78

11.24

5.5

3.2

—

Pediculosis, acariasis and other infestations

201

1198

1.70

11.20

4.3

3.6

—

Malignant neoplasm of mesothelium and soft tissue

246

2.63

11.20

2.7

3.7

—

Amputation of foot

207

2.81

11.18

8.6

3.6

—

Hypothermia

137

3.28

11.15

4.5

3.8

—

Adhesive capsulitis of shoulder

212

1284

1.67

11.13

3.6

3.7

—

Acute bronchiolitis

340

2.29

11.12

6.8

3.6

—

Other shoulder lesions

119

606

1.99

11.12

3.8

3.5

—

Benign paroxysmal vertigo

382

2637

1.46

11.12

3.6

3.5

—

Other and unspecified injuries of lower leg

104

505

2.09

11.11

3.6

3.5

—

Social phobias

100

478

2.12

11.09

2.1

2.9

—

Myocardial infarction, with ST-elevation

271

1745

1.57

11.09

5.0

3.8

—

Asthma and opportunity respiratory infection

326

2.39

11.07

5.2

4.0

—

Other arterial embolism and thrombosis

208

2.78

11.03

6.0

3.7

—

Ovarian cyst

407

1614

1.46

11.01

3.2

—

Hidradenitis suppurativa

202

2.79

11.01

5.8

2.8

—

Diseases of spleen

108

3.57

10.99

5.4

3.7

—

Malignant neoplasm of other and unspecified parts of biliary tract

4.05

10.99

2.4

3.2

—

Viral warts

262

1676

1.58

10.98

4.9

3.5

—

Asthma mixed form (mode)

213

2.72

10.97

2.4

2.7

—

Acute nephritic syndrome

128

3.32

10.95

7.0

3.0

—

Cyst of kidney

115

584

2.01

10.93

5.4

3.8

—

Periodontitis

1277

6958

1.23

10.91

3.7

3.6

—

Metabolic disorder, other/unspecified

16.42

10.89

2.5

—

Multiple myeloma

160

3.03

10.85

3.9

3.7

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

160

3.03

10.85

3.9

3.7

—

Congenital malformations of heart and great arteries

171

954

1.76

10.81

4.4

4.1

—

Migraine with aura and triptan purchases

167

955

1.77

10.81

2.5

3.0

—

Impetigo

274

2.50

10.81

3.8

3.1

—

Superficial injuries involving multiple body regions

155

3.06

10.80

2.9

2.8

—

Event of undetermined intent

438

2.16

10.79

3.9

3.5

—

Seronegative rheumatoid arthritis

151

840

1.82

10.78

3.1

3.3

—

Lifestyle-related condition

4.33

10.78

3.9

2.5

—

Coxarthrosis [arthrosis of hip](FG)

695

3712

1.32

10.75

3.6

3.5

—

Mycoses

1110

7795

1.24

10.71

4.1

3.5

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

100

3.62

10.70

8.2

2.8

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

5.33

10.70

4.2

1.7

—

Open wound of wrist and hand

574

4173

1.35

10.69

3.3

3.7

—

Myopia

148

822

1.82

10.61

4.5

3.4

—

Neuralgia and neuritis, unspecified

301

2.41

10.59

2.9

3.5

—

General examination and investigation of persons without complaint and reported diagnosis

933

3824

1.28

10.58

3.8

3.5

—

Cluster headache, wide

173

2.89

10.54

4.5

3.2

—

Heterophoria

106

529

2.04

10.53

4.0

3.5

—

Syphilis

163

2.98

10.51

8.0

3.5

—

Syphilis

163

2.98

10.51

8.0

3.5

—

Oesophagitis

391

2.22

10.50

5.3

3.8

—

Other abnormal uterine and vaginal bleeding

268

1233

1.57

10.47

3.3

—

Polyglandular dysfunction

17.39

10.47

8.9

1.5

—

Explicit fungal Sepsis

8.07

10.46

11.7

2.1

—

Viral infections of the central nervous system

470

2.10

10.45

4.2

3.6

—

Molar incisor enamel hypoplasia

183

2.80

10.44

13.1

3.4

—

Other specific joint derangements/joint disorders

888

4507

1.28

10.44

3.7

3.4

—

Other noninfective disorders of lymphatic vessels and lymph nodes

214

2.68

10.41

5.1

3.6

—

Tumor necrosis factor alpha inhibitors

183

1086

1.70

10.41

2.7

3.5

—

3.83

10.38

3.8

2.0

—

Alzheimer disease, excluding more controls

218

877

1.65

10.37

3.3

3.6

—

Cerebral palsy and other paralytic syndromes

154

873

1.79

10.35

4.6

3.8

—

Ulcerative rectosigmoiditis

109

553

2.00

10.35

3.6

3.7

—

Pre-eclampsia

195

1178

1.67

10.34

3.3

2.7

—

Disorders of purine and pyrimidine metabolism

9.23

10.34

7.0

2.0

—

Disorders of phosphorus metabolism and phosphatases

11.05

10.31

4.4

2.2

—

Assault by bodily force

103

513

2.04

10.30

3.6

3.1

—

Malignant neoplasm of heart, mediastinum and pleura

4.28

10.29

3.0

2.8

—

Paralytic ileus

269

2.48

10.27

3.9

3.7

—

Seborrhoeic dermatitis

137

752

1.85

10.27

5.8

3.7

—

Polyuria

295

1968

1.51

10.26

3.4

3.6

—

Urethral stricture

461

2.11

10.25

4.2

4.1

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

344

2.29

10.21

3.2

3.9

—

Evidence of alcohol involvement determined by level of intoxication

4.52

10.19

3.6

2.4

—

Visual field defects

128

690

1.89

10.19

4.2

3.9

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

128

690

1.88

10.16

3.6

3.9

—

Other/unspecified rheumatoid arthritis

171

1005

1.72

10.14

4.4

3.6

—

Disorders of optic nerve and visual pathways

124

662

1.90

10.14

4.4

3.5

—

Assault by other specified means

5.01

10.14

3.9

2.5

—

Pleural plaque without asbestos

321

2.35

10.14

4.3

4.0

—

Lesion of ulnar nerve

181

1080

1.70

10.13

3.9

—

Chronic periodontitis, including avohilmo

1265

6961

1.22

10.07

3.8

3.6

—

Dislocation, sprain and strain of joints and ligaments of head

218

2.62

10.02

4.2

3.5

—

Injuries involving multiple body regions

248

2.52

10.01

2.9

3.4

—

Varicose veins

794

4688

1.29

9.98

4.0

3.5

—

malignant neoplasm of male genital organs

409

1755

1.43

9.95

3.7

4.0

—

Benign neoplasm: Pancreas

174

2.85

9.94

4.9

3.9

—

Autoimmune polyglandular failure

28.12

9.93

8.3

1.3

—

Evidence of alcohol involvement determined by blood alcohol level

3.66

9.91

2.9

2.7

—

Iridocyclitis

286

1911

1.51

9.88

3.9

3.7

—

Injuries to the wrist and hand

1313

7518

1.21

9.83

3.3

3.6

—

Assault by unspecified means

116

3.29

9.83

3.9

3.5

—

Primary open-angle glaucoma, strict

369

2588

1.44

9.82

4.1

3.7

—

Hypermobility syndrome

268

2.43

9.82

2.7

—

Use of trihexyphenidyl

26.61

9.81

6.5

2.2

—

Certain conditions originating in the perinatal period

105

472

2.00

9.80

6.4

3.2

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

132

727

1.84

9.80

3.6

3.9

—

Diabetes mellitus in pregnancy

289

1221

1.52

9.79

2.6

—

Disorders of adrenal gland, other and/or unspecified

9.94

9.79

3.0

2.0

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

3.68

9.76

2.0

2.5

—

Abscess of anal and rectal regions

114

600

1.93

9.75

4.0

3.8

—

Adalimumab

117

621

1.91

9.74

2.6

3.7

—

Injury of other and unspecified intrathoracic organs

103

525

2.00

9.73

4.1

—

Trigger finger

169

1001

1.71

9.72

3.5

3.6

—

Thyroiditis, ILD-related definition

135

750

1.82

9.72

3.4

3.2

—

Fracture of skull and facial bones

261

1717

1.53

9.71

3.2

3.8

—

Hepatocellular carcinoma, including Hilmo

199

2.69

9.70

3.9

4.0

—

Tracheo-bronchomalasia

16.17

9.69

2.2

3.8

—

Scabies

166

980

1.71

9.67

4.6

3.6

—

Primary hyperparathyroidism

144

818

1.79

9.66

4.5

3.4

—

Malignant neoplasm of liver and intrahepatic bile ducts

194

2.71

9.63

4.1

—

Acute and subacute iridocyclitis

244

1586

1.55

9.61

3.9

3.7

—

Primary open-angle glaucoma

441

3099

1.39

9.61

3.8

3.7

—

Other symptoms and signs involving general sensations and perceptions

284

2.38

9.59

4.9

3.6

—

Neovascular glaucoma

303

2.33

9.58

5.4

3.7

—

Visual disturbances

609

4650

1.32

9.57

3.7

3.6

—

Malignant neoplasm of small intestine, including Hilmo

178

2.77

9.51

4.7

3.5

—

!Aliquae complicationes praecoces traumatis

304

2.32

9.50

5.2

3.8

—

Early complications of trauma

304

2.32

9.50

5.2

3.8

—

Mantle cell lymphoma

4.60

9.50

3.4

2.5

—

Chronic sinusitis

525

3925

1.34

9.49

3.6

3.5

—

Anankastic personality disorder

195

2.67

9.48

1.6

2.8

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

189

1162

1.65

9.46

5.4

3.6

—

Psoriasis

351

2462

1.44

9.45

4.1

3.6

—

Psoriatic arthropathies

127

700

1.84

9.41

3.0

3.3

—

Amiodarone users

154

900

1.74

9.40

3.6

4.1

—

Infections with a predominantly sexual mode of transmission

415

2788

1.39

9.38

4.0

3.2

—

Glaucoma secondary to other eye disorders

306

2.31

9.37

5.4

4.0

—

Benign neoplasm: Adrenal gland

110

582

1.92

9.32

3.7

3.8

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

319

2205

1.46

9.32

4.3

3.6

—

Microscopic polyangiitis

5.40

9.29

8.3

2.7

—

Diabetic neuropathy

222

1422

1.58

9.28

6.4

4.0

—

Inflammatory diseases of the central nervous system

113

604

1.90

9.26

5.7

3.8

—

Malignant neoplasm of rectum

126

697

1.83

9.25

3.7

3.9

—

Pyoderma gangrenosum

5.05

9.21

6.5

2.5

—

Hypertension, Pulmonary Arterial

7.40

9.18

5.4

2.4

—

ILD and respiratory illness in diseases classified elsewhere

7.49

9.14

8.1

2.5

—

Acquired haemolytic anaemia

154

2.88

9.13

5.9

3.7

—

Visual disturbances and blindness

654

5076

1.29

9.08

3.8

3.6

—

Sequelae of injuries of upper limb

128

716

1.81

9.07

3.2

3.7

—

Malignant neoplasm of brain

194

2.64

9.06

2.4

3.6

—

Allergic bronchopulmonary aspergillosis (ABPA)

25.88

9.06

5.8

2.6

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

9.43

9.06

7.9

2.2

—

Injury of unspecified body region

111

595

1.90

9.04

4.6

3.9

—

Malignant neoplasm of prostate, including Hilmo

409

1742

1.41

9.04

3.8

4.1

—

Hepatocellular carcinoma

133

3.03

9.04

4.7

4.0

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

212

2.55

9.02

4.9

3.0

—

Keratitis

436

3199

1.37

9.02

4.4

3.5

—

Vitamin B12 deficiency anaemia

148

865

1.73

9.01

3.8

3.6

—

Recurrent and persistent haematuria

4.56

9.01

4.6

1.8

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

4.51

8.99

4.6

2.9

—

Nonhereditary hypogammaglobulinemia

4.51

8.98

6.2

3.0

—

Malignant neoplasm, without specification of site, including Hilmo

324

2.23

8.98

2.8

3.8

—

Symptoms and signs involving emotional state

178

2.70

8.95

4.1

3.6

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

5.10

8.94

4.5

2.5

—

Malignant neoplasm of prostate

396

1693

1.41

8.92

3.7

4.1

—

Soft tissue disorders related to use, overuse and pressure

325

2274

1.44

8.90

3.8

3.6

—

Haemolytic anaemias

238

2.46

8.90

6.0

3.9

—

Presence of other devices

115

2030

0.56

8.88

2.6

3.5

—

Coxarthrosis

640

3259

1.30

8.85

3.7

3.6

—

Other/unspecified mastoiditis and related conditions

7.60

8.82

2.2

2.7

—

Hyperplasia of prostate

536

2283

1.34

8.82

4.0

—

Pre-eclampsia or eclampsia

205

1307

1.58

8.81

3.4

2.9

—

Secondary parkinsonism, excluding more controls

135

2.96

8.78

5.0

3.8

—

Thyrotoxicosis

294

2026

1.46

8.75

3.0

3.5

—

Other disorders starting during childhood or adolescence

318

2.22

8.73

5.0

4.0

—

Acute gastritis

103

546

1.92

8.69

4.7

3.6

—

Viral infections of the central nervous system

518

1.94

8.68

4.1

3.7

—

7.40

8.67

8.5

2.6

—

Poisoning by medicine, drug-induced

3.93

8.62

3.1

2.6

—

Secondary malignant neoplasm of respiratory and digestive organs

3.46

8.59

1.6

3.2

—

Ulcerative colitis (strict definition, require KELA)

201

1285

1.58

8.58

3.2

3.7

—

Myositis

148

2.84

8.57

5.1

3.9

—

Other and unspecified coagulation defects

305

2.24

8.56

5.2

3.4

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

194

1231

1.59

8.55

3.3

3.7

—

Familial hypercholesterolemia, with ischemic heart disease

128

730

1.78

8.54

3.8

3.7

—

Heartburn

122

685

1.80

8.54

3.5

3.7

—

Chronic myeloproliferative disease

3.71

8.52

2.6

2.9

—

Other/unspecified seropositive rheumatoid arthritis

320

2253

1.43

8.51

4.3

3.5

—

Strabismus

314

2197

1.44

8.50

4.6

3.6

—

Other and unspecified follicular disorders

268

2.33

8.50

4.7

3.3

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

214

1391

1.55

8.49

3.2

3.6

—

Anterior Iridocyclitis

254

1713

1.50

8.48

3.9

3.7

—

Membranous nephropathy

8.38

8.46

7.4

2.7

—

Sequelae of infectious and parasitic diseases

100

530

1.91

8.45

4.3

3.7

—

Hepatomegaly and splenomegaly, not elsewhere classified

4.83

8.44

7.4

3.0

—

Benign neoplasm of colon, rectum, anus and anal canal

840

5877

1.25

8.44

4.2

3.6

—

Intussusception

101

3.25

8.43

3.8

4.0

—

Excessive, frequent and irregular menstruation

426

1699

1.38

8.43

3.0

3.2

—

Nonsuppurative otitis media

270

1589

1.48

8.43

4.9

3.3

—

Carcinoma in situ of skin, other sites/unspecified

107

3.23

8.41

5.2

3.8

—

Striking against or struck by other objects

407

2987

1.37

8.39

3.5

3.8

—

Extrapyramidal and movement disorders

490

3704

1.33

8.37

3.6

3.7

—

Tobacco use

361

2.12

8.34

5.2

3.6

—

Arthropathic psoriasis

138

810

1.72

8.31

3.5

3.9

—

Gingivitis and periodontal diseases

1386

6014

1.19

8.31

3.7

3.5

—

Exposure to other specified factors

943

7076

1.23

8.30

3.7

3.6

—

Other congenital malformations

103

554

1.88

8.29

4.7

3.8

—

Excessive attrition of teeth

657

5168

1.28

8.27

3.9

3.5

—

Parkinson's disease, strict definition, excluding more controls

148

842

1.69

8.26

3.2

3.7

—

Cluster headache, strict

168

2.67

8.24

4.8

3.1

—

Wet age-related macular degeneration

254

1672

1.49

8.22

3.5

3.7

—

Seropositive rheumatoid arthritis, wide

321

2276

1.42

8.22

4.3

3.5

—

Polycythaemia vera

204

2.51

8.22

3.6

3.9

—

Orchitis and epididymitis

136

798

1.73

8.22

4.1

4.3

—

Other and unspecified immunodeficiencies with predominantly antibody defects

3.90

8.17

8.6

2.4

—

malignant neoplasm of female genital organs

158

959

1.65

8.17

3.1

3.4

—

Intracranial and intraspinal abscess and granuloma

3.79

8.14

3.4

2.6

—

Allergic urticaria

100

537

1.89

8.12

3.8

3.4

—

Hyperhidrosis

119

2.99

8.12

2.9

2.8

—

Complications of genitourinary prosthetic devices, implants and grafts

147

2.79

8.11

3.5

—

Unspecified misadventure during surgical and medical care

399

2.04

8.11

4.6

3.8

—

Other disorders of optic [2nd] nerve and visual pathways

447

1.98

8.10

5.0

3.6

—

Assault by sharp object

104

3.18

8.08

6.3

3.7

—

Disorders of vestibular function (Vertigo)

583

4458

1.29

8.07

3.3

3.6

—

Osteonecrosis due to drugs

3.47

8.05

3.5

3.8

—

Papulosquamous disorders

471

3561

1.33

8.05

4.0

3.6

—

Volvulus

171

2.64

8.01

4.5

3.8

—

Disorders of vitreous body and globe

627

4728

1.28

8.01

4.5

3.7

—

Toxic effect of corrosive substances

7.50

7.98

3.4

4.5

—

Other and unspecified epidermal thickening

154

2.73

7.98

6.3

4.1

—

Striae atrophicae

4.58

7.98

3.0

1.7

—

Other and unspecified mental retardation

3.22

7.96

4.0

4.9

—

Cardiac murmurs and other cardiac sounds

102

548

1.86

7.95

3.7

3.5

—

Disorders of continuity of bone

114

642

1.80

7.95

4.8

3.5

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

322

2.16

7.94

3.6

4.3

—

Colon adenocarcinoma

152

928

1.66

7.92

3.6

3.7

—

Pain in thoracic spine

173

1090

1.60

7.90

3.6

3.5

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

3.55

7.87

1.7

2.1

—

Cachexia

7.98

7.86

5.6

4.1

—

Spondylopathies (FG)

158

975

1.64

7.86

3.0

3.2

—

Other and unspecified spinal muscular atrophies

4.39

7.86

4.1

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

8.84

7.84

4.4

1.9

—

Other neurotic disorders

330

2.13

7.83

4.6

3.9

—

Rare circulating lymphoid malignancy, including Hilmo

179

2.58

7.82

4.3

4.2

—

Bacterial, viral and other infectious agents

112

631

1.80

7.81

4.7

3.8

—

Peptic ulcer

4.03

7.81

2.9

3.3

—

Need for other prophylactic measures

391

2.03

7.80

4.3

4.1

—

Viral encephalitis, not elsewhere classified/unspecified

128

2.90

7.79

5.2

3.7

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

446

1.96

7.79

2.6

3.5

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

3.64

7.78

1.7

2.7

—

Other and unspecified hydrocephalus

123

2.94

7.75

5.4

3.4

—

Disorders of synovium and tendon

626

4316

1.28

7.73

3.6

—

Preterm labour and delivery

238

1614

1.48

7.73

3.0

3.2

—

Melanocytic naevi, other sites/unspecified

101

554

1.85

7.71

6.6

3.7

—

Other disorders of bone

228

1536

1.50

7.69

4.3

3.5

—

Pilonidal cyst

540

1.85

7.67

3.2

3.3

—

Wide developmental disorders

192

2.49

7.67

2.6

4.1

—

Autism

140

2.77

7.67

2.2

3.2

—

Dislocation, sprain and strain of joints and ligaments at neck level

169

1068

1.60

7.64

2.8

3.5

—

Pain and other conditions associated with female genital organs and menstrual cycle

201

1210

1.54

7.63

2.0

3.0

—

Haemorrhoids and perianal venous thrombosis

390

2885

1.36

7.63

3.7

3.6

—

Other and unspecified abdominal hernia

308

2.16

7.59

4.2

4.1

—

Myeloproliferative diseases

118

682

1.76

7.59

3.4

3.8

—

Persistent delusional disorders

543

1.85

7.57

3.7

3.6

—

Malignant neoplasm of endocrine gland

402

1.99

7.56

4.8

3.6

—

Bacterial, viral and other infectious agents

106

594

1.81

7.55

4.6

3.9

—

IBD (strict) with PSC

4.56

7.51

5.8

3.5

—

Infection of intervertebral disc (pyogenic)

3.39

7.50

4.2

4.0

—

Ulcerative enterocolitis

195

2.46

7.49

3.1

3.5

—

3.20

7.47

4.0

2.9

—

Coeliac disease

146

896

1.65

7.47

4.6

3.6

—

Crohn disease (strict definition, require KELA)

418

1.97

7.46

2.6

3.6

—

Other bursopathies

163

1028

1.60

7.46

4.8

3.7

—

Other specified/unspecified inflammatory spondylopathies

251

2.26

7.46

2.2

3.5

—

Any dementia, excluding more controls

481

2522

1.32

7.44

3.1

3.6

—

Disorders of vitreous body

604

4606

1.27

7.42

4.5

3.7

—

Myelodysplastic syndrome, including Hilmo

190

2.48

7.41

3.6

—

Thyrotropin deficiency

3.75

7.41

4.5

2.4

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

9.00

7.40

10.5

2.1

—

Localized skin eruption due to drugs and medicaments

3.74

7.40

5.7

2.3

—

Malignant melanoma, including Hilmo

203

1348

1.52

7.38

3.4

3.7

—

Superficial injury of ankle and foot

138

838

1.66

7.36

4.2

3.7

—

Other bacterial agents as the cause of diseases classified to other chapters

3.43

7.36

8.5

2.6

—

Mantle cell lymphoma, including Hilmo

3.34

7.35

3.3

3.7

—

Olecranon bursitis

477

1.90

7.35

5.3

4.2

—

SLE (Finngen)

155

2.63

7.32

4.2

3.3

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

105

3.04

7.32

3.2

—

Congenital iodine-deficiency syndrome/hypothyroidism

173

2.54

7.32

3.9

3.6

—

Chronic hepatitis, not elsewhere classified

191

2.46

7.32

5.5

3.1

—

Chronic myeloid leukaemia, including Hilmo

4.47

7.31

2.2

2.4

—

Other female pelvic inflammatory diseases

165

1049

1.59

7.29

2.6

3.0

—

Urethritis and urethral syndrome

116

2.92

7.28

4.7

3.2

—

Magnesium deficiency

13.28

7.27

3.7

2.0

—

Crohn disease (strict definition, require KELA, min 2 HDR)

408

1.96

7.27

2.6

3.5

—

Unspecified/other endometriosis

485

1.87

7.25

2.6

—

Open wound of abdomen, lower back and pelvis

198

2.43

7.25

4.6

3.9

—

Atopic dermatitis, strict definition with reimbursement

311

2165

1.39

7.22

4.5

3.1

—

Chronic laryngitis and laryngotracheitis

177

1147

1.56

7.22

3.8

3.5

—

Primary biliary cholangitis (PBC)

3.18

7.19

5.9

3.7

—

Mesothelioma

3.93

7.19

3.4

2.7

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

262

2.22

7.19

2.8

3.6

—

Superficial injury of forearm

121

715

1.71

7.18

4.5

3.7

—

Small fibre neuropathy

206

2.39

7.14

4.2

3.7

—

Osteopathy in diseases classified elsewhere

4.42

7.13

4.9

2.7

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

161

1023

1.59

7.13

3.4

2.8

—

Pneumoconiosis due to asbestos and other mineral fibres

182

2.49

7.12

3.5

3.7

—

Intercostal neuropathy

4.06

7.11

5.8

2.4

—

Other orthopaedic follow-up care

316

2.09

7.08

2.5

3.1

—

Oesophageal obstruction

251

2.24

7.08

3.3

4.1

—

Other conditions related to polyarteritis nodosa

10.63

7.06

2.8

3.6

—

Paraplegia, diplegia of upper limbs

147

2.66

7.04

3.9

3.4

—

Myeloid leukaemia

183

2.47

7.02

3.8

3.9

—

Obsessive-compulsive disorder

351

2.02

7.00

2.6

2.8

—

Other and unspecified injuries of ankle and foot

259

2.20

6.95

4.6

3.3

—

Acquired absence of organs, not elsewhere classified

3.68

6.95

7.3

3.2

—

Non-small cell lung cancer, squamous

346

2.03

6.94

4.3

4.2

—

Appendicitis, broad definition

901

6761

1.21

6.92

3.6

—

Hypertrophic cardiomyopathy

327

2.06

6.90

6.2

4.0

—

Diseases of appendix

908

6797

1.21

6.89

3.6

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

560

1.79

6.89

6.0

3.6

—

Superficial injury of wrist and hand

225

1548

1.46

6.87

3.6

3.8

—

Other noninflammatory disorders of vulva and perineum

100

567

1.78

6.87

3.9

3.2

—

Sequelae of other and unspecified infectious and parasitic diseases

334

2.04

6.85

4.5

3.2

—

Other specified/unspecified necrotizing vasculopathies

3.18

6.84

6.0

2.8

—

Follicular lymphoma, hilmo

315

2.08

6.81

3.1

3.9

—

Hydrocele

172

1125

1.55

6.77

4.0

4.2

—

Use of antiglaucoma preparations and miotics

112

660

1.72

6.76

3.9

3.8

—

Defects in the complement system

5.78

6.75

2.8

2.6

—

Anuria and oliguria

4.23

6.74

9.4

3.1

—

Chorioretinal inflammation

168

2.50

6.74

3.5

—

Caries of enamel

758

6666

0.82

6.73

3.3

3.5

—

Intracerebral haemorrhage

176

1159

1.53

6.71

4.0

3.8

—

Other maternal disorders predominantly related to pregnancy

520

2540

1.29

6.71

2.9

3.1

—

Primary gonarthrosis, bilateral

653

4505

1.25

6.70

3.2

3.8

—

Vulvovaginal ulceration/inflammation in other diseases

303

2.07

6.68

3.8

2.8

—

Cryoglobulinemia

16.87

6.67

5.2

4.6

—

Degenerative macular diseases

164

1066

1.56

6.66

3.8

3.7

—

Hydrocephalus in other diseases

5.69

6.64

5.9

2.6

—

Osteomyelitis of vertebra

8.21

6.64

9.1

2.5

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

342

2544

1.35

6.63

3.9

3.6

—

Lumbar disc prolapse

752

4713

1.23

6.62

3.2

3.6

—

Disturbances of skin sensation

301

2195

1.38

6.62

2.8

3.4

—

Malignant neoplasm of eye, brain and central nervous system

258

2.17

6.61

2.3

3.6

—

Bronchitis, not specified as acute or chronic

545

1.78

6.59

3.0

3.3

—

Autism spe

140

2.63

6.59

1.6

3.2

—

Other specified/unspecified spondylopathies

152

2.56

6.58

4.8

4.0

—

Fall on same level involving ice and snow

691

5623

1.23

6.58

3.6

—

Other intervertebral disc disorders

1011

5104

1.20

6.56

3.2

3.5

—

Dermatophytosis

166

1086

1.54

6.55

5.1

3.9

—

Sleep disorders, other/unspecified

195

2.35

6.54

4.1

3.5

—

Other specified congenital malformation syndromes affecting multiple systems

3.14

6.53

6.9

4.5

—

Other bacterial agents as the cause of diseases classified to other chapters

3.53

6.52

8.2

2.4

—

Superficial injury of shoulder and upper arm

138

866

1.61

6.52

3.3

3.7

—

Portal vein thrombosis

3.01

6.51

3.2

3.9

—

Other strabismus

241

1692

1.43

6.50

4.9

3.5

—

Salpingitis and oophoritis

174

1151

1.52

6.49

4.6

3.0

—

Other and unspecified psoriasis

490

1.82

6.48

3.9

4.0

—

Other disorders of eyelid

563

4271

1.26

6.47

3.1

3.7

—

Other and unspecified trigeminal disorders

3.06

6.46

1.6

3.2

—

Small cell lung cancer

142

2.59

6.42

3.5

3.7

—

Small cell lung cancer, including Hilmo

142

2.59

6.42

3.5

3.7

—

Acute nasopharyngitis (common cold)

134

832

1.61

6.42

2.9

3.4

—

Fall on and from stairs and steps

311

2294

1.36

6.40

4.1

3.6

—

Crystal arthropathies, rheuma endpoint

131

2.68

6.39

5.4

3.1

—

Use of rotigotine

3.58

6.38

4.8

3.1

—

Otitis externa

262

1881

1.40

6.37

4.8

3.6

—

Organ-limited amyloidosis

7.50

6.36

2.6

2.7

—

Diabetes insipidus

3.99

6.34

3.8

2.4

—

Mixed connective tissue disease

386

1.92

6.33

5.0

3.8

—

Car occupant injured in other and unspecified transport accidents

212

1468

1.45

6.31

3.7

3.5

—

Coxibs

417

1670

1.32

6.30

3.3

4.4

—

Aspergillosis

3.83

6.30

4.4

3.0

—

Generalized epilepsy

250

2.15

6.30

4.0

3.7

—

Normotensive glaucoma

118

720

1.66

6.29

3.1

3.8

—

Postprocedural disorders of nervous system

401

1.89

6.27

3.5

2.9

—

Chondrocostal junction syndrome [Tietze]

225

2.22

6.24

2.9

3.3

—

Exclusion endpoint for clefts

2.92

6.24

6.6

5.2

—

Acne

106

628

1.70

6.23

7.2

2.8

—

Stomatitis and related lesions

227

1596

1.43

6.23

3.6

—

Cramp and spasm

305

2.03

6.23

3.0

3.5

—

Contusion of other and unspecified parts of foot

298

2.04

6.22

3.3

3.2

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

388

1.90

6.21

2.6

2.2

—

Congenital malformations and deformations of the musculoskeletal system

120

733

1.64

6.18

4.8

3.6

—

Haemorrhage in early pregnancy

242

1675

1.41

6.18

2.6

3.0

—

Kela reimbursement Agammaglobulinemia (D80-84)

3.92

6.18

5.0

2.3

—

Other disorders of amino-acid metabolism

7.15

6.17

4.9

5.3

—

Conjunctivitis (acute, non atopic)

314

2324

1.35

6.17

4.2

3.6

—

360

1.93

6.16

4.3

3.6

—

Other crystal arthropathies

134

2.61

6.12

5.4

3.1

—

Carpal tunnel syndrome

713

5164

1.22

6.11

3.4

3.5

—

Aggressive periodontitis

140

2.57

6.10

2.8

—

Ehlers-Danlos syndrome

3.69

6.10

1.9

1.5

—

Pruritus

128

803

1.61

6.08

5.4

3.4

—

Disorders of tooth development and eruption

171

920

1.51

6.06

4.2

3.1

—

Infections with a predominantly sexual mode of transmission

300

2216

1.36

6.06

4.7

3.2

—

Symptoms and signs involving the skin and subcutaneous tissue

861

7063

1.20

6.04

3.6

—

Malignant neoplasm of thyroid gland

364

1.92

6.03

4.9

3.4

—

Abnormal findings in nipple discharge synovial fluid wound secretions

3.07

6.03

5.3

2.2

—

Unspecified protein-energy malnutrition

4.25

6.02

3.7

3.1

—

Benign neoplasm of middle ear and respiratory system

106

637

1.69

6.01

3.1

4.0

—

Juvenile arthritis (FINNGEN)

255

2.11

6.00

4.2

3.4

—

Fall involving bed

243

2.15

5.97

3.9

4.3

—

Sequelae of injuries of neck and trunk

185

2.32

5.93

4.1

3.4

—

Ulcer of vagina/vulva

142

2.52

5.91

3.7

3.0

—

Acute myeloid leukaemia and myelodysplastic syndromes

107

2.78

5.91

5.9

3.4

—

Thyrotoxicosis with diffuse goitre

141

911

1.56

5.90

2.8

3.2

—

Proteinuria and renal glomerular damage; focal glomerulonephritis

12.66

5.90

10.7

4.4

—

Diseases of salivary glands

360

2748

1.32

5.90

3.1

3.5

—

Behavioural disorders, excluding more controls

2.94

5.90

5.8

3.5

—

Artificial joint operation, meniscal resection

1175

6548

1.17

5.90

3.4

3.7

—

Ventricular septal defect, a heart condition

136

2.55

5.89

4.8

4.1

—

Malignant melanoma

164

1097

1.51

5.87

3.5

3.7

—

Injury of intra-abdominal organs

161

2.41

5.86

5.7

2.8

—

Toxic liver disease

2.94

5.85

3.8

2.9

—

Underdevelopment of the second kidney

12.18

5.84

16.3

2.5

—

Monoarthritis, not elsewhere classified

258

2.09

5.84

4.4

3.3

—

Eustachian salpingitis and obstruction

484

1.77

5.83

4.4

2.9

—

Other and unspecified injuries of thorax

108

2.76

5.82

3.1

3.5

—

Spontaneous rupture of synovium and tendon

589

1.70

5.82

2.8

3.9

—

Ulcer of oesophagus

552

1.73

5.82

5.6

4.0

—

Anisometropia and aniseikonia

206

2.23

5.81

5.0

3.5

—

Malignant immunoproliferative diseases

3.47

5.81

4.8

3.3

—

D07AA Corticosteroids, weak (group I)

173

1170

1.49

5.81

3.4

3.7

—

Fissure and fistula of anal and rectal regions

268

1963

1.37

5.81

3.4

3.5

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

4.08

5.80

4.3

2.9

—

Neuroendocrine tumor and carcinoma of small intestine

3.33

5.79

2.9

2.7

—

UC patients in KELA-register (code 208), prior to 1994

300

2.00

5.79

3.5

4.0

—

Infectious mononucleosis

522

1.74

5.79

3.9

2.7

—

Fracture of neck

501

1.76

5.79

4.0

3.9

—

Otalgia

560

1.72

5.79

3.5

3.6

—

Other psoriatic arthropathies

117

728

1.62

5.78

2.8

3.8

—

Alcoholic gastritis

103

2.81

5.78

4.8

4.7

—

Memory loss

812

0.45

5.77

3.9

—

Achalasia of cardia

103

2.79

5.76

3.6

4.1

—

Nonspecific lymphadenitis

349

1.91

5.75

4.6

3.5

—

Menorrhagia

356

1492

1.33

5.75

2.9

3.2

—

Other diseases of gallbladder

294

2.00

5.73

5.3

3.4

—

Acute epiglottitis

3.11

5.70

6.0

3.3

—

Intermittent heterotropia

371

1.88

5.70

6.2

3.6

—

Ovarian dysfunction

364

1.89

5.69

2.3

2.2

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

188

2.27

5.67

5.6

3.7

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.87

5.63

3.6

4.8

—

Other and unspecified nerve root and plexus disorders, also in other diseases

218

1552

1.41

5.63

3.7

—

Psoriatic arthropathies, ICD10

119

749

1.61

5.62

2.7

3.9

—

Seropositive rheumatoid arthritis, strict definition

170

1157

1.48

5.61

4.1

3.6

—

Hypersomnia

3.08

5.59

4.0

2.9

—

Abnormal reflex

5.20

5.58

5.0

2.5

—

Maternal care for other known or suspected fetal problems

207

914

1.44

5.57

2.3

2.6

—

Pain associated with micturition

134

869

1.56

5.56

3.8

3.6

—

Encephalopathy

3.26

5.56

7.8

3.1

—

Acute appendicitis

825

6491

1.19

5.54

3.7

3.6

—

Carcinoid syndrome

3.47

5.53

2.9

3.3

—

Atrophic disorders of skin

155

1039

1.50

5.51

3.1

3.2

—

Myeloproliferative diseases (CML excluded)

100

607

1.67

5.50

3.6

3.9

—

Hypersensitivity angiitis

5.97

5.50

4.9

3.2

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

116

731

1.60

5.47

3.6

4.0

—

Deficiency of other B group vitamins

118

2.60

5.43

6.2

3.3

—

Shoulder lesions

929

4771

1.18

5.43

3.3

3.6

—

Congenital malformations and deformations of the musculoskeletal system

582

1.67

5.43

5.0

3.5

—

Systemic sclerosis (FG)

118

2.59

5.42

4.9

2.9

—

Corneal ulcer

207

1471

1.42

5.42

4.4

3.7

—

Thrombotic microangiopathy

4.98

5.42

5.4

2.9

—

Alkalosis

12.29

5.42

9.2

3.0

—

Acne vulgaris

495

1.73

5.41

5.4

2.8

—

3.70

5.41

4.5

3.3

—

Calculus of lower urinary tract

482

1.75

5.40

3.0

4.1

—

Malignant neoplasm of breast, HER2-negative

373

1880

1.30

5.40

3.3

3.2

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

3.53

5.38

2.2

3.2

—

Spondylolisthesis/Spondylolysis

201

1423

1.42

5.38

2.9

3.6

—

Other appendicitis

595

1.66

5.37

3.8

—

Problems related to social environment

174

2.28

5.37

3.7

3.1

—

Other overlap syndromes

2.85

5.36

4.0

3.2

—

Poor fetal growth

103

633

1.64

5.35

3.5

2.5

—

L04AC Interleukin inhibitors

358

1.87

5.35

2.9

3.7

—

Malignant neoplasm of other connective and soft tissue

137

2.46

5.35

2.6

3.6

—

Other epidermal thickening

309

1.94

5.34

5.5

3.8

—

Benign neoplasm: Colon

690

5480

1.21

5.34

4.2

3.7

—

Other specified/unspecified bacterial intestinal infections

483

1.74

5.34

4.1

3.8

—

Hypersensitivity pneumonitis due to organic dust

2.79

5.33

8.3

3.2

—

Carcinoma in situ of other and unspecified sites

317

1.94

5.33

3.0

4.1

—

Triptan medication for migraine, min. 3 purchases

552

3416

1.24

5.33

2.7

3.3

—

Acetic acid derivatives and related substances

410

1656

1.29

5.31

3.9

4.4

—

Other congenital malformations of heart

6.16

5.29

2.0

4.7

—

Hypertension, portal

7.97

5.28

4.6

2.2

—

Inflammatory disease of uterus

127

824

1.55

5.26

3.0

2.8

—

Post-traumatic wound infection, not elsewhere classified

176

2.26

5.25

5.6

3.3

—

Malignant neoplasm of renal pelvis, including Hilmo

3.04

5.22

5.1

3.0

—

Other specified/unspecified systemic involvement of connective tissue

347

1.87

5.21

5.1

3.6

—

Impaction of intestines

5.07

5.21

3.3

3.7

—

Secondary parkinsonism+Parkinsonism in other disease

190

2.20

5.18

4.9

4.4

—

Other and unspecified urticaria

211

1517

1.40

5.18

3.9

3.6

—

Somnolence

3.09

5.16

7.6

2.7

—

Inflammatory diseases of prostate (prostatitis)

169

1170

1.46

5.16

4.5

4.1

—

Diseases of inner ear

652

5237

1.21

5.15

3.4

3.6

—

Hypotension due to drugs

104

2.68

5.14

4.5

3.7

—

534

3989

1.23

5.11

4.4

3.6

—

Personal history of medical treatment

3.67

5.10

5.5

2.7

—

Malignant neoplasm of oesophagus, including Hilmo

252

2.02

5.08

3.0

4.0

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

5.91

5.07

3.8

4.8

—

Malignant neoplasm of head and neck

566

1.66

5.07

4.3

4.0

—

Cluster headache, wide,, including avohilmo

329

1.88

5.06

3.9

3.1

—

Polymyalgia rheumatica

173

1208

1.45

5.06

3.5

3.8

—

Postzoster neuralgia

2.70

5.05

4.4

4.1

—

3.05

5.05

2.4

2.6

—

Anosmia

4.50

5.04

4.2

1.5

—

Henoch-Schönlein purpura nephritis (HSPN)

6.46

5.04

7.7

2.3

—

Benign neoplasm: Skin, unspecified

260

1.99

5.02

3.4

—

Malignant neoplasm of breast, HER-positive

285

1674

1.33

5.01

3.2

—

Enteropathic arthropathies

123

2.49

5.00

2.8

2.5

—

Pregnancy hypertension

360

2515

1.29

5.00

3.3

3.0

—

Cystic fibrosis

8.48

5.00

5.9

2.0

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

380

1922

1.28

4.98

3.4

3.2

—

Malignant neoplasm of breast, including Hilmo

380

1922

1.28

4.97

3.4

3.2

—

Malignant neoplasm of breast

373

1897

1.29

4.97

3.3

3.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

441

1.74

4.95

4.3

3.2

—

Other injuries of spine and trunk, level unspecified

3.46

4.95

4.9

2.9

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

174

2.23

4.95

4.1

3.9

—

Malignant neoplasm of pancreas

487

1.70

4.93

3.4

3.9

—

Dependent personality disorder

112

2.56

4.92

3.6

3.1

—

Benign neoplasm: Colon, unspecified

313

2410

1.31

4.92

4.2

3.7

—

Calcinosis cutis

12.74

4.92

10.3

1.6

—

Drug-induced interstitial lung disorders, unspecified

12.70

4.92

4.3

2.9

—

Universal erythroderma, KELA reimbursement

2.78

4.91

4.8

3.1

—

Muscle strain

168

2.24

4.91

4.0

3.5

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

299

2288

1.31

4.90

2.5

3.6

—

Infections of genitourinary tract in pregnancy

510

1.68

4.89

3.7

3.0

—

Other and unspecified diseases of spleen

5.58

4.89

4.1

3.0

—

Ehlers-Danlos syndrome

4.35

4.88

1.9

1.7

—

Lupus nephritis

6.90

4.87

8.7

1.5

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

137

2.38

4.87

2.9

3.2

—

Gonarthrosis, primary, with knee surgery

728

4881

1.19

4.87

3.4

3.8

—

Other specified/unspecified disorders of bone/cartilage

182

2.19

4.86

2.9

4.0

—

Viral meningitis

215

2.08

4.86

3.0

3.1

—

Actinic keratosis

497

3744

1.24

4.86

4.2

3.6

—

Carcinoma in situ, bladder

285

1.94

4.85

2.9

4.0

—

Hypoplasia of dental enamel, prenatal

8.16

4.85

18.7

6.6

—

Other secondary gonarthrosis

400

1.78

4.85

3.8

3.7

—

Artrosis, including avohilmo

1075

5089

1.16

4.85

3.2

3.7

—

Use of riluzole

5.06

4.83

4.8

2.6

—

Other juvenile arthritis

229

2.04

4.83

4.3

3.3

—

Malignant neoplasm of ureter, including Hilmo

3.41

4.82

4.3

2.7

—

Brain glioblastoma and astrocytoma

2.80

4.82

1.9

3.4

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

401

2769

1.26

4.81

3.4

3.0

—

Autoimmune hyperthyroidism

335

1.84

4.79

3.1

3.0

—

Mental and behavioural disorders due to hallucinogens

4.93

4.78

7.4

1.5

—

Artificial joint re-operation

561

1.64

4.77

3.2

4.0

—

Disorder of the sleep-wake schedule

2.66

4.77

3.8

3.4

—

Dronedarone medication

151

2.29

4.77

1.8

3.3

—

Spirochaetal infections, other/unspecified

672

0.46

4.75

5.0

3.9

—

Agoraphobia

164

2.23

4.74

2.8

2.5

—

Other skin changes

227

1679

1.36

4.74

4.7

3.8

—

Malignant neoplasm, without specification of site

204

2.09

4.73

2.7

3.6

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

2.72

4.73

5.2

4.0

—

Motor disorders, excluding more controls

3.22

4.72

6.0

4.4

—

Malignant neoplasm of corpus uteri, including Hilmo

601

1.61

4.71

2.8

3.3

—

Other and unspecified haemorrhagic conditions

2.70

4.71

2.3

3.1

—

Skin changes due to chronic exposure to nonionizing radiation

506

3818

1.23

4.70

4.2

3.7

—

Other extrapyramidal and movement disorders in other diseases

273

2077

1.32

4.70

3.6

—

conjunctival haemorrhage

618

1.61

4.69

4.1

3.9

—

Medical observation and evaluation for suspected diseases and conditions

879

3836

1.18

4.68

3.6

3.5

—

Diaphragmatic hernia

426

3427

1.25

4.68

3.4

3.7

—

Other drug-induced secondary parkinsonism

3.32

4.68

7.8

2.5

—

Synovial cyst of popliteal space [Baker]

525

1.66

4.68

3.8

3.9

—

Diseases of external ear

398

3178

1.26

4.68

4.3

3.6

—

Myotonic disorders

3.62

4.67

2.5

2.4

—

Suggestive for eosinophilic asthma

106

681

1.57

4.67

4.2

3.8

—

Other and unspecified intracranial injuries

212

2.07

4.67

3.8

4.1

—

Malignant neoplasm of breast, ER-positive, including Hilmo

287

1688

1.32

4.66

3.2

3.3

—

Diffuse brain injury

185

2.14

4.65

5.1

3.6

—

Personal history of allergy to drugs, medicaments and biological substances

3.57

4.65

5.4

2.4

—

Burn and corrosion of trunk

199

2.10

4.64

2.8

3.6

—

Other infective spondylopathies

10.98

4.63

5.1

3.0

—

Congenital malformations of trachea and bronchus

3.08

4.63

7.9

3.7

—

Other enthesopathies

307

2378

1.30

4.62

3.6

—

Allergic purpura

186

2.13

4.61

4.1

3.0

—

Malignant neoplasm of thyroid gland, including Hilmo

428

1.72

4.61

4.7

3.4

—

Chronic lymphocytic leukaemia, helper endpoint

173

2.18

4.61

4.3

3.6

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

173

2.18

4.61

4.3

3.6

—

Chronic lymphocytic leukaemia

173

2.18

4.61

4.3

3.6

—

Dementia, including avohilmo

615

3521

1.21

4.60

2.9

3.8

—

Speech and linguistic disorders

101

617

1.58

4.60

3.8

3.7

—

Other and unspecified acquired haemolytic anaemias

3.16

4.58

4.9

2.9

—

Hyperprolactinaemia

160

2.22

4.58

5.0

2.4

—

Ulcerative colitis (strict) with PSC

4.33

4.58

3.8

3.7

—

Small cell lung cancer, helper endpoint

167

2.20

4.57

3.5

3.9

—

Secondary parkinsonism

187

2.13

4.57

5.0

4.2

—

Fistulae involving female genital tract

2.78

4.56

3.9

3.1

—

Congenital malformations of gallbladder, bile ducts and liver

3.26

4.55

15.2

2.5

—

Non-small cell lung cancer, squamous, helper endpoint

401

1.75

4.53

4.3

4.1

—

Paranoid personality disorder

2.58

4.51

4.2

2.3

—

Reactive arthropathies

616

1.59

4.50

4.8

3.5

—

Dermatopolymyositis (FG)

2.84

4.50

5.0

2.8

—

Other disorders of central nervous system

3.00

4.49

2.8

4.1

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

243

1.97

4.48

4.0

4.1

—

Nontraumatic intracranial haemmorrhage

251

1902

1.33

4.47

4.5

3.7

—

Sudden idiopathic hearing loss

121

809

1.51

4.46

4.5

3.8

—

Malignant neoplasm of oesophagus

169

2.17

4.45

3.2

3.9

—

Lesion of lateral popliteal nerve

366

1.77

4.45

4.2

3.8

—

Hypothyroidism due to medicaments and other exogenous substances

2.91

4.45

5.3

3.2

—

Tuberculosis, IBD comorbidity

587

1.60

4.45

4.0

3.8

—

Tic and related disorders

3.07

4.44

2.0

3.9

—

Mental disorders, not otherwise specified

494

1.65

4.43

3.0

3.3

—

Bulimia nervosa (incl. atypical)

143

2.26

4.42

4.1

2.4

—

Atrial septal defect, secundum type

182

2.12

4.42

5.6

4.2

—

Other and unspecified injuries of shoulder and upper arm

203

2.05

4.41

4.3

3.6

—

Psoriasis vulgaris

209

1545

1.36

4.41

4.4

3.7

—

Cystic fibrosis with intestinal manifestations

13.10

4.40

3.0

1.8

—

Use of rasagiline

170

2.16

4.40

2.7

3.7

—

Embolism and thrombosis of abdominal aorta

9.81

4.40

3.9

2.2

—

Fibrosis of liver

3.48

4.40

5.1

2.2

—

Etanercept

397

1.73

4.39

2.6

3.6

—

Shock, not elsewhere classified

3.43

4.37

7.7

3.2

—

Ocular pain

566

1.61

4.37

4.0

3.4

—

Persons encountering health services in circumstances related to reproduction

440

3639

0.81

4.36

3.3

3.7

—

Immunodeficiency associated with other major defects

12.43

4.34

11.0

1.3

—

Trigeminal neuralgia

376

1.75

4.34

3.2

3.7

—

Malignant neoplasm of larynx, including Hilmo

132

2.32

4.34

5.6

4.0

—

Accidental poisoning by and exposure to alcohol

101

2.53

4.34

2.6

2.8

—

Malignant neoplasm of vulva, including Hilmo

2.85

4.34

3.3

3.1

—

Systemic sclerosis

132

2.32

4.33

4.9

3.3

—

Gonarthrosis,primary

1124

6072

1.14

4.31

3.3

3.8

—

Benign neoplasm of other and ill-defined parts of digestive system

206

1526

1.36

4.30

4.4

3.6

—

Atrial septal defect

238

1.95

4.30

5.7

4.2

—

Diplopia

155

1096

1.43

4.29

3.0

3.7

—

Nummular dermatitis

101

656

1.56

4.28

5.1

3.8

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

5.11

4.28

4.2

2.6

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

3.12

4.28

5.1

4.0

—

Carcinoma in situ of skin of scalp and neck

213

2.02

4.28

5.9

3.9

—

Haemolytic-uraemic syndrome

7.57

4.28

10.1

3.4

—

Follow-up examination after treatment for conditions other than malignant neoplasms

376

3100

0.80

4.28

3.2

3.5

—

Hypoplasia of dental enamel, prenatal , including avohilmo

5.09

4.27

18.5

4.8

—

Retinal detachment with retinal break

154

1089

1.43

4.27

4.3

3.9

—

Herpesviral [herpes simplex] infections

248

1890

1.32

4.25

4.1

3.2

—

Other and unspecified primary disorders of muscles

3.55

4.24

5.8

2.5

—

Vascular dementia (undefined)

331

1.79

4.24

2.8

4.0

—

Dystonia

357

1.76

4.22

2.4

3.5

—

Cervicalgia

221

1659

1.34

4.22

2.9

3.5

—

Cluster headache, strict, including avohilmo

313

1.81

4.21

4.1

3.1

—

Impingement syndrome of shoulder

141

1996

0.70

4.21

3.4

3.8

—

Malignant neoplasm of pancreas, including Hilmo

619

1.57

4.21

3.3

3.9

—

Dementia in Alzheimer disease

249

1603

1.32

4.20

3.3

3.9

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Gas panel - Central venous blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS